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Abstract 
Classic lesion experiments from the 1940s have established the hypothalamus as 
playing an essential role in controlling energy homeostasis. Gold-thioglucose (GTG) 
induces lesions in the ventromedial nucleus of the hypothalamus (VMH) resulting in 
hyperphagia and obesity. To identify genes involved in the hypothalamic regulation of 
energy homeostasis, we employed a screen to search for genes that were dysregulated in 
GTG induced obese mice. In this screen, GPR7, the endogenous G protein-coupled 
receptor (GPCR) for the recently identified ligands neuropeptide B (NPB) and 
neuropeptide W (NPW), was found to be specifically down-regulated after GTG 
treatment. 
The physiological role of GPR7 was investigated by generating and analyzing 
mice with targeted disruption of GPR7. Male GPR7-/- mice developed an adult-onset 
obesity syndrome that progressively worsened with age and was greatly exacerbated 
when animals were fed a high fat diet. Male GPR7A mice were hyperphagic and had 
decreased energy expenditure and locomotor activity. These mice also had an abnormal 
response to fasting-induced feeding but not to glucoprivic-induced feeding suggesting 
that central response to glucose was normal. The hypothalamic RNA levels of 
neuropeptide Y and proopiomelanocortin in male GPR7-/- mice were more indicative of a 
lean state than a leptin deficient "starved" state. Furthermore, ob/ob GPR7-/- and Ay/a 
GPR7-/- double mutant male mice were heavier than normal ob/ob or Ay/a male mice 
suggesting that the obesity of GPR7 -/- mice is independent of leptin and melanocortin 
signaling. Interestingly, female GPR7-/- mice did not show any significant weight 
increase or associated metabolic defects. Additionally, other behavioral paradigms were 
investigated in the GPR7-/- mice. Baseline sleep-wake cycles, circadian rhythms, 
anxiety-like behaviors, and depression-like behaviors were all normal in GPR7-/- mice. 
Therefore, these behavioral disorders can not account for the feeding disorders seen in 
GPR7-/- mice. 
In aggregate, these data strongly suggest a physiological role for GPR7 and its 
endogenous ligands, NPB and NPW, as a catabolic signaling pathway independent of 
leptin and melanocortin pathways. Future studies of GPR7, its ligands, and the GPR7 
knockout mice will further elucidate the full range of physiological functions of this 
novel signaling pathway. 
Chapter 1: Introduction 
Obesity: Medical epidemic and its prevalence in society 
While a comprehensive coverage of obesity as a medical epidemic in modern 
society is beyond the scope of this introduction, a brief overview of the topic is presented 
below. Obesity has become a major health problem since the late 20th century in the 
Western world. From 1980 to 1994, there was an increase in the prevalence of obesity 
(defined as a Body Mass Index or BMI over 30, where BMI is the weight of a person in 
kilograms divided by the height of a person in meters squared) from 14.5% to 22.5% in 
the US population (Taubes, 1998). This increasing obesity trend continues to rise as in 
1999-2000 the-age adjusted prevalence of obesity was 30.5% with extreme obesity (BMI 
> 40) significantly increasing from 2.8% to 4.7% (Flegal et al., 2002). The latest Center 
for Disease Control (CDC) data strongly shows the increased prevalence of obesity 
throughout the US adult population from 1991 to 2002 (Figure 1). Furthermore, the 
obesity epidemic is spreading to other parts of the world such as Brazil and Africa that 
typically had low to practically no incidence of obesity (Kopelman, 2000). 
Obesity Trends* Among U.S. Adults 
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Figure 1) Obesity trends among US adults from 1991 to 2002. Source: CDC's Behavioral Risk Factor 
Surveillance System (BRFSS). 
T h e medical cost associated with obesity and obesity-related conditions is 
rapidly rising. An increase in body weight (BMI) has been found to be associated with 
an increase risk factor for type 2 diabetes, hypertension, coronary heart disease, 
gallstones, dyslipidemia, osteoarthritis, sleep apnea, and some form of cancers 
(Kopelman, 2000). Obesity-related health issues are now approaching smoking as the 
number one cause of preventable mortality in the modern US society with 400,000 deaths 
compared to 435,000 deaths from smoking in the year 2000 (Mokdad et al., 2004). 
With the overwhelming clinical, epidemiological, and basic science data supporting 
obesity as a major health epidemic, the study of the causes of obesity and the 
development of safe and effective treatments for obesity are essential. 
The causes of obesity have long been debated. While the popular press and 
companies promoting diet programs have advocated the need to lose weight by going on 
special diets or by simply eating less, often shifting the blame to an individual's 
lack-of-willpower, the problem is not so easily solved. Almost all dieters who lose 
weight rebound back to their original weight within months of starting their diet (Wadden, 
1993). Gastric bypass or bariatric surgery has been found to be the most effective 
therapeutic option for morbidly obese patient with nearly all patients losing a significant 
amount of their body weight immediately after surgery (Fisher and Schauer, 2002). 
However, rebound weight gain is still a large concern even among these patients. The 
surgery often forces the patients to change their normal eating habits as it may actually 
reduce physical hunger as well as decreasing the stomach's physical capacity to hold 
food; however, binge-eating or grazing is still seen postoperatively especially among 
patients that had eating disorders prior to surgery (Kalarchian et al., 2002; Saunders, 
2001; Saunders, 2004). Patients who have some rebounding in weight after bariatric 
surgery may constitute a significant portion of obese patients undergoing this operation. 
Hence, long-term body weight is physiologically regulated by some rigid 
homeostatic controller despite even radical attempts to physically or psychologically 
change it. This idea has led to the "set point" theory. In this theory, energy stores and 
therefore body weight are maintained at constant levels by long-term regulators that 
coordinates food intake and energy expenditure (Friedman and Leibel, 1992). Energy 
homeostasis can be considered as the balance between energy intake by food intake and 
energy expenditure by metabolic activity including physical activity and thermogenesis. 
This balance between energy intake and energy expenditure may be similar and related to 
other physiological homeostatic controls such as osmotic and thermal homeostasis. 
Strong evidences for genetics playing a key role in regulating one's body weight 
are emerging from several studies. The classical "gold standard" for determining 
whether there is a genetic contribution of a known disease or disorder is by studying 
monozygotic twins who have been reared together, sharing the same environment, to 
those who have been reared apart, living in different environmental conditions. Studies 
have found that obesity, especially in terms of BMI, is strongly influenced by genetic 
factors for both monozygotic twins raised together or apart (Allison et al., 1996; Stunkard 
et al., 1986; Stunkard et al., 1990). Body mass index and body weight had similar 
heritability as height at 20 years of age and after a 25 year follow-up study on the same 
group (Stunkard et al., 1986). Furthermore, the heritability of obesity can be considered 
higher than many diseases and disorders commonly thought as having a genetic 
component including schizophrenia, breast cancer, and heart disease. Therefore, the 
elucidation of the key genetic and physiological factors affecting energy homeostasis is 
essential for developing new therapeutic medical interventions. 
Early studies in obesity from lesions to mouse mutants 
Classic lesion experiments have placed specific regions of the brain namely the 
hypothalamus as playing a major role in maintaining energy homeostasis. As early as 
the 1940s and 1950s, it was known that lesions in certain hypothalamic nuclei caused 
either a rapid hyperphagia and obesity or hypophagia and starvation (Anand and Brobeck, 
1951; Hetherington and Ranson, 1940). Hypothalamic lesions were induced in rodents 
either by electrical or chemical means such as by gold thioglucose (GTG) (Figure 2). 
Anatomical studies of these animals have shown that the region leading to hyperphagia 
after lesions was in the ventromedial nucleus of the hypothalamus (VMH). These nuclei 
were named the "satiety center." The lateral hypothalamic (LH) nucleus corresponded 
to the region leading to hypophagia after lesions and was called the "feeding center." 
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Figure 2) Rats with hypothalamic lesions as originally described by Hetherington and Ranson in their 
classic 1940 paper (Hetherington and Ranson, 1940). 
Several theories on the maintenance of energy homeostasis emerged in the late 
1940s and 1950s. The first proposed by Brobek stated that feeding behavior was 
controlled by the normal body temperature of an animal (Brobeck, 1947). According to 
this thermostatic theory, "animals eat to keep warm, and stop eating to prevent 
hyperthemia." The lipostatic theory was proposed by Kennedy to rebuke the thermostat 
theory (Kennedy, 1953). In this theory, a "chemical limiting factor" existed from the fat 
depot that would act as a signal to the hypothalamus. Therefore, this circulating 
metabolite from fat would be the primary controller of energy homeostasis and not body 
temperature. A third theory was soon proposed afterwards. Mayer hypothesized that 
glucose was the main determinant of energy homeostasis (Mayer, 1953; Mayer, 1955; 
Mayer and Thomas, 1967). This glucostatic theory was based on the fact that glucose is 
the primary energy source for the CNS. Glucose stores in liver and skeletal muscle get 
depleted over the course of a day and was therefore theorized to be the main regulatory 
element in energy homeostasis (Mayer and Thomas, 1967). 
In 1950, perhaps the strongest evidence for genetics controlling in part obesity 
was seen in Jackson Laboratories (Coleman, 1978; Ingalls et al., 1950). The ob/ob 
obese mice were first discovered as a spontaneous autosomal recessive mutation in a 
noninbred stock. The ob mutation was then placed on a C57BL/6J strain and resulted in 
marked obesity, hyperphagia, transient hyperglycemia, and elevated plasma insulin. 
This mutation also resulted in infertility in both sexes. In 1966, another mutation called 
diabetes (db/db) was discovered in a C57BL/KsJ mouse line (Hummel et al., 1966). 
Obesity, hyperphagia, and severe diabetes with marked hyperglycemia characterized the 
db/db mutants. While having a similar phenotype with the C57BL/6J ob/ob mice, the 
C57BL/Ks db/db mice's diabetes were more severe and had a less pronounced obesity. 
Another allele db2J/ db2J arose in the Jackson Laboratories in the C57BL/6J strain. The 
phenotype of the db2J/ db2J mutants and the C57BL/6J ob/ob were similar suggesting that 
they had mutations in the same pathway. When the db2J/ db2J allele was placed on a 
C57BL/Ks background, it showed the same phenotype as the original db/db mice. This 
established that db2V db2J and the original db/db were the same genetic mutation and that 
the ob and db genes were probably two different genes affecting the same pathway. 
Parabiosis experiments, where the circulatory system of two animals are joined, 
between ob/ob, db/db, and normal mice by Coleman and his colleagues suggested that the 
normal mice produced a satiety factor that was either lacking in the ob/ob mice or 
unresponsive in the db/db mice (Coleman and Hummel, 1969; Coleman, 1973). In these 
experiments, either ob/ob or db/db mice had their circulatory system joined with that of a 
normal mouse. For the case of the db/db parabiosis, the normal parabiont stopped 
eating, rapidly lost weight, became hypoglycemic and eventually died of starvation, while 
the db/db mice maintained its hyperphagia and obesity. However, the normal parabiont 
to an ob/ob mouse did not develop these effects and instead decreased the weight and 
food intake of the ob/ob mouse. Furthermore, when an ob/ob mouse was parabiosed to 
a db/db mouse, the initially hyperphagic and obese ob/ob mouse rapidly lost weight and 
eventually died of starvation. It was concluded that a defect in the ob/ob mice resulted 
in the lack of production of a satiety factor, while a defect in the db/db mice led to it 
being unable to respond to this satiety factor and perhaps producing an abnormally high 
level of the factor. Coleman suggested that a primary hypothalamic defect could be 
involved in these mice in particular with the db/db mice. This hypothesis was bolstered 
by an earlier parabiosis study where VMH lesioned rats were parabiosed to normal rats 
and had a similar result to that of Coleman's parabiosis experiments with db/db mice 
(Hervey, 1959). The normal parabiont rat soon stopped eating and died of starvation, 
while the VMH lesioned rat maintained its hyperphagia and obesity. These db/db mice 
may have a defective "satiety center" analogous to those rodents with VMH lesions. 
The ob gene could be producing the factor that was first proposed in the lipostat theory 
by Kennedy in 1953. From the 1950s to early 1990s, most of the studies on obesity and 
energy homeostasis revolved around these themes using lesion experiments, the 
spontaneously arising obese mouse mutants, and animal physiology studies. 
Leptin: The start of the molecular genetics era of obesity 
In 1994, a basic molecular understanding of the energy homeostasis circuit was 
solved in part by the positional cloning of the ob gene leading to the discovery of leptin 
(Zhang et al., 1994). The immediate impact of this discovery is unquestionable. The 
identification of leptin and the subsequent cloning of the leptin receptor gene, db, by 
expression and positional cloning of the db/db mutant mice confirmed Kennedy's lipostat 
theory and Coleman's theories based on his earlier parabiosis experiments (Chen et al., 
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1996; Chua et al., 1996; Lee et al., 1996; Tartaglia et al., 1995). ob/ob mutant mice had 
a single point mutation that changed an arginine to a stop codon leading to the absence of 
leptin production. Leptin is a 16 kDa circulating (167 amino acid) cytokine hormone 
produced primarily in the adipocytes but also in lower amounts in other tissues such as 
the placenta, skeletal muscle, and gastric epithelium (Bado et al., 1998; Masuzaki et al., 
1997; Wang et al., 1998). The initial and subsequent data have shown that leptin is the 
afferent signal in a negative-feedback loop regulating the size of adipose tissue mass 
(Friedman and Halaas, 1998). Levels of leptin correlate with adipose tissue mass and 
decrease after a fall in body weight in both humans and mice (Maffei et al., 1995; 
McGregor et al., 1996). 
Leptin has many pleiotropic effects when administered at pharmacological doses 
(Figure 3) (Ahima and Flier, 2000; Friedman and Halaas, 1998). When leptin is 
administered to ob/ob mice, most of the abnormalities seen in the ob/ob mice are 
corrected (Campfield et al., 1995; Halaas et al., 1995; Pelleymounter et al., 1995). The 
ob/ob mice decrease its food intake and increase its energy expenditure. Diabetes, 
infertility, fatty liver, and hypothermia are all reversed after leptin treatment (Ahima et al., 
1996; Chehab et al., 1996; Halaas et al., 1997; Pelleymounter et al., 1995). The 
phenotypic abnormalities displayed by the ob/ob mice are similar to many of those seen 
12 
in starved animals. Therefore, decreased leptin might be signaling starvation in animals 
(Ahima et al., 1996). Injections into wildtype mice also lead to hypophagia and adipose 
tissue loss (Halaas et al., 1997; Halaas et al., 1995). However, the weight loss is strictly 
in adipose tissue and can not be caused solely by the decrease in food intake (Levin et al., 
1996). Therefore, leptin must have a vital role in other complex metabolic pathways 
such as lipid metabolism. Leptin may also be playing a physiological role in regulating 
the onset of puberty. Female mice treated with leptin develop puberty faster and have a 
generally accelerated onset of reproductive cycle and capacity (Ahima et al., 1997; 
Chehab etal., 1997). 
The main action of leptin is thought to occur in the central nervous system 
(CNS). Initial pharmacological studies with leptin showed that very low doses given as 
intracerebroventricular (ICV) injections (3ng/hour or 200 fmoles/hour) had the same 
effects as those of 100 to 1000 times higher doses given peripherally (Campfield et al., 
1995; Halaas et al., 1997). This suggested that the leptin receptor might be located in 
the CNS, possibly in the same regions as seen in the classic lesion studies of the 1940s 
and 1950s. However, it remained possible that leptin might also directly affect adipose 
tissue, liver, and other peripheral organs in light of leptin's multi-faceted role. 
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Figure 3) Leptin is an adipocyte derived hormone that is part of an afferent loop that regulates energy 
homeostasis and other physiological systems (Friedman and Halaas, 1998). The main site of action is 
believed to be the hypothalamus through the circumventricular organ (CVO); however, there remains the 
possibility that leptin may have direct actions on peripheral tissues such as T-cells as well. 
Leptin receptor and the neural circuit of energy homeostasis 
Expression cloning identified a receptor (Ob-R) with high affinity for leptin 
from mouse choroid plexus (Tartaglia et al., 1995). Positional cloning of the various 
db/db mutant mice and the fatty rat further validated that this was the endogenous 
receptor for leptin (Chen et al., 1996; Chua et al., 1996; Lee et al, 1996). Ob-R has at 
least five alternatively spliced isoforms Ob-R (a-e) and is a member of the class I 
cytokine receptor family, most closely related with IL-6 receptor, glycoprotein 130, 
leukemia inhibitory factor, and granulocyte-colony stimulating factor (Figure 4) 
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(Friedman and Halaas, 1998). All the isoforms of Ob-R have identical long 
extracellular domain for ligand binding but differ in the C-terminus. All isoforms of the 
leptin receptor except Ob-Re have a membrane spanning region. Ob-Rb, the long 
isoform, has a long cytoplasmic tail with consensus Jak-Stat binding motifs with three 
tyrosines that function as phosphorylation targets for SH-2 domain proteins. Other 
signaling pathways may also be involved as activation of Ob-Rb and possibly Ob-Ra can 
promote Jak-dependent, STAT-independent pathways such as MAP kinases. 
Ob-Ra Ob-Rb Ob-Rc Ob-Rd Ob-Re 
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Figure 4) Leptin receptor isoforms and receptor mutations in rodents (Friedman and Halaas, 1998). A ) 
The five known isoforms of the leptin receptor. There are possibly others. B) Ob-R mutations in rodent 
modes of obesity. 
The various db/db mutations lead to a defect in all the isoforms of Ob-R except 
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C57BL/Ks db/db. The C57BL/Ks db/db mutant was found to have a premature stop 
codon leading to a defective Ob-Rb isoform while the other isoforms remained intact 
(Chen et al., 1996; Lee et al., 1996). Since the phenotype of C57BL/Ks db/db mice is 
indistinguishable from other strains of db/db mice, which have complete inactivity of all 
isoforms of Ob-R, Ob-Rb was considered the main signaling receptor critical for leptin 
function. The physiological roles that other Ob-R isoforms might have are presently 
unknown. Ob-Ra has a short tail that is missing many of the putative signaling domains 
possessed by Ob-Rb, but it can mediate signal transduction in vitro (Bjorbaek et al., 
1997). Some researchers believe that short isoforms of the leptin receptor such as 
Ob-Ra might be involved in leptin transport into the CNS (Hileman et al., 2002; Uotani et 
al., 1999). Ob-Re, on the other hand, has been suggested to be a secreted soluble 
receptor that binds to leptin in the plasma (Lee et al., 1996; Liu et al., 1997). 
While Ob-R is expressed in almost all known tissues, the hypothalamus has 
particularly high expression levels of Ob-Rb (Fei et al., 1997; Mercer et al., 1996; 
Tartaglia et al., 1995). This data with the pharmacological evidence suggest that leptin's 
main site of action may be in the hypothalamic area classically thought to regulate energy 
homeostasis. In situ hybridization studies have shown high Ob-Rb expression in the 
arcuate nucleus, dorsomedial hypothalamus (DMH), VMH, paraventricular nucleus 
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(PVN), and lateral hypothalamus (LH) (Elmquist et al., 1998; Fei et al., 1997). Stat3 
activation is seen after injection of leptin in the hypothalamus of all mice possessing an 
active Ob-Rb (Vaisse et al., 1996). Fos expression in the hypothalamus is also induced 
by peripheral leptin injections (Elias et al., 2000). Leptin signaling through Ob-R is 
negatively regulated by SHP-2, a phosphatase that decreases JAK2 phosphorylation, and 
SOCS-3 (Bjorbaek et al., 1998; Carpenter et al., 1998; Li and Friedman, 1999; Myers, 
2004). The localization of leptin receptor in the hypothalamus, the pharmacological 
data showing a higher efficacy in ICV injections versus peripheral injections, and the 
activation of known signaling molecules in the hypothalamus strongly point to the 
hypothalamus as the main site of leptin's action. Furthermore, a brain specific deletion 
of the leptin receptor using the cre-lox system in mice has led to an identical, at least in 
regards to energy homeostasis, phenocopy to the db/db mutation (Cohen et al., 2001). 
After the cloning of leptin and its receptor, a rapidly growing list of 
neurotransmitters, neuropeptides, and hormones and their receptors have been found to 
be involved in the hypothalamic regulation of energy homeostasis (Table 1) (Salton et al., 
2000). While other peripheral signals such as insulin may have a role, leptin appears to 
be a central factor in the neural circuit in energy homeostasis (Schwartz et al., 2000). A 
broad overview of the known signaling pathways has leptin, synthesized in the adipose 
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tissue, acting on neurons in the arcuate nucleus with stimulation also of the V M H and 
dorsomedial nucleus. As mentioned above, lesions of the arcuate and VMH lead to 
obesity, while LH causes leanness. The arcuate neurons express Ob-R and either 
NPY/AgRP or POMC/CART coexpressing neurons (Cheung et al., 1997; Hahn et al., 
1998; Kristensen et al., 1998). NPY is a potent anabolic/orexigenic molecule, while 
POMC expresses a-MSH, a strong catabolic/anorectic peptide affecting the melanocortin 
signaling pathway (Clark et al., 1984; Poggioli et al., 1986). AgRP is an endogenous 
orexigenic peptide inhibitor of melanocortin signaling (Ollmann et al., 1997). CART is 
a relatively recently identified anorectic peptide hormone regulated by leptin (Kristensen 
et al., 1998). From the arcuate nucleus, the signal is transmitted to other various 
hypothalamic nuclei, most notably the lateral hypothalamus (LH) and paraventricular 
nucleus (PVN). The paraventricular nuclei contain both NPY receptors and 
melanocortin receptors. In the PVN, stimulation of the melanocortin receptors by 
a-MSH results in a catabolic effect, while inhibition of the melanocortin receptors by 
AgRP results in an anabolic effect. The activation of NPY receptors in the PVN acts as 
an anabolic signal. With this dual regulation of energy homeostasis, the PVN may act 
as the integratory nuclei for the hypothalamic energy homeostasis pathway. In the LH, 
there are also melanocortin receptors and NPY receptors. The LH contains at least two 
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Table 1: List of some of the known factors (neurotransmitters and peptides) regulating feeding behavior 
when centrally administered by ICV injections. Leptin might regulate some or all of these signals. 
Nearly all known receptors in this pathway are GPCRs. 
Stimulatory / Anabolic 
Neuropeptide Y (NPY) 
Melanin-concentrating hormone (MCH) 
Galanin 
Orexin a and b 
Peptide Y Y 
Norepinephrine (a2 receptor) 
Agouti-related protein (AgRP) 
Ghrelin 
Opioids 
Inhibitory / Catabolic 
ct-Melanocyte-stimulating hormone (a-MSH) 
Cocaine-amphetamine-related transcript (CART) 
Cholecystokinin (CCK) 
Corticotropin-releasing factor (CRF) 
Glucagon-like peptide 1 (GLP-1) 








Calcitonin-gene related peptide (CGRP) 
Prolactin-releasing peptide (PrRP) 
Adrenomedullin 
Pituitary adenylate-cyclase activating polypeptide (PACAP) 
Interleukin-1 (3 
Insulin 
Norepinephrine (P receptor) 
neuronal cell populations involved in energy homeostasis, the melanin-concentrating 
hormone (MCH) containing neurons and the orexin containing neurons (Qu et al., 1996; 
Sakurai et al., 1998). Release of either peptide causes a stimulation of feeding response 
in rodents. This complex neural circuit is only beginning to be unfolded as more 
hormones, neurotransmitters, and peptides are implicated in this pathway at an 
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astounding pace. 
Candidate obesity genes: Genetic versus pharmacological evidences 
While at pharmacological doses several molecules have been found to stimulate 
or inhibit food intake and generally regulate aspects of energy homeostasis, it is not 
known whether this correlates to an actual endogenous physiological function. It may 
simply be due to some pharmacological "side-effect." For finding an obesity drug, this 
may be sufficient. However, if one wants to find the true physiological pathway of 
energy homeostasis, this is insufficient. To try to delineate between a pharmacological 
role and a physiological role of these signaling molecules, knockout and transgenic mice 
of many of these molecules and their receptors have been made. Surprisingly, several of 
these transgenic and knockout animals show a different or no obvious or striking 
feeding-related phenotype. These includes NPY, AgRP, CRF, CCK, GLP-1, and 
ghrelin (Erickson et al., 1996a; Kopin et al., 1999; Muglia et al., 1995; Qian et al., 2002; 
Scrocchi et al., 2000; Sun et al., 2003). The initial lack of a phenotype in energy 
metabolism can be due to several reasons. These molecules may have redundant roles 
with other similar signaling mechanism, or there may be compensatory changes with a 
loss of one of these factors. One could expect that since energy homeostasis is vital to 
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life there could be several redundant mechanisms in the event that one of them fails. In 
a related manner, these signaling factors may only be essential under certain conditions 
such as during fasting or chronic stress that were not tested in the initial characterization 
of these transgenic and knockout mice. 
Another approach to the analysis of these potential signaling molecules would be 
to state that any effects seen in energy homeostasis were purely pharmacological or 
secondary to their "true" physiological role. This might be the case with orexin. 
Orexin was initially identified as a neuropeptide that when centrally administered to rats 
caused a hyperphagic response (Sakurai et al., 1998). While orexin appears to still play 
a role in energy homeostasis, it may have a stronger role in vigilance and wakefulness as 
indicated by the narcoleptic phenotypes of the orexin knockout mice and the naturally 
occurring orexin receptor 2 mutant dogs (Chemelli et al., 1999; Lin et al., 1999). 
Likewise, CRF may pharmacologically be considered an anorectic peptide, but its main 
role may be more closely related to controlling stress and anxiety through stimulating 
glucocorticoid release (Muglia et al., 1995). Neither CRF nor its receptor knockout 
mice displayed a striking obesity phenotype (Bale et al., 2000; Kishimoto et al., 2000; 
Muglia et al., 1995; Smith et al., 1998). 
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While some studies have failed to find a large effect from monogenic 
manipulations in mice, knockout and transgenic studies have been "successful" in 
showing a physiological role in many other molecules including the melanocortin 
receptors, POMC, MCH, and serotonin receptors (Huszar et al., 1997; Nonogaki et al., 
1998; Shimada et al., 1998; Yaswen et al., 1999). All of these mice showed a 
phenotype as expected from earlier pharmacological studies. Final validation for some 
of these factors has come from the identification of monogenic obesity syndromes in 
morbidly obese human patients (Farooqi and O'Rahilly, 2004). 
Additional gene targeting and transgenic studies might also help to identify 
physiological roles for each newly identified gene such as with Cidea and bombesin 
receptor subtype 3 (Ohki-Hamazaki et al., 1997; Zhou et al., 2003). The immediate 
mechanism leading to the obesity phenotype for these animals is often unknown. Many 
genes that were initially not directly linked to obesity have been found to give rise to an 
obese animal when manipulated or knocked-out such as with syndecan-3, a cell surface 
heparan sulfate proteoglycan (Reizes et al., 2001). A relatively recent genetic and a 
pharmacological model of the neural circuit modulating energy homeostasis are shown 
below (Figure 5A and B). The picture of the neural circuit of energy homeostasis is a 












Figure 5: Models, One Based on Genetic and the Other on Pharmacological Data, of the Hypothalamic 
Pathways that Regulate Energy Balance (Salton et al., 2000). Two models are presented, one consistent 
with genetic (A) and the other with pharmacological (B) data. The caliber of the arrows is proportionate to 
the impact that the anorexigenic (darlc/red) or orexigenic (light/green) pathways have on feeding and/or 
metabolism. Pathways that appear to have a lesser impact on energy metabolism have been left out for the 
sake of simplicity. The melanocortin, M C H , and leptin pathways have been implicated by genetic and 
pharmacological studies as being critical regulators of energy homeostasis and so arc depicted in both 
panels. Major contributions of NPY, orexin, -endorphin, CRF, and GLP-1 to the control of energy balance 
are not supported by genetic analyses, and so these pathways are shown only in (B). Abbreviations: A G R P , 
agouti-related peptide; -MSH, -melanocyte-stimulating hormone; A R C , arcuate nucleus; -end, -endorphin; 
CRF, corticotropin-releasing factor; CRF-R1, C R F receptor 1; D M H , dorsomedial hypothalamus; GLP-1, 
glucagon-like peptide 1; GLP-1 R. GLP-1 receptor, Lep-R, leptin receptor; L H A , lateral hypothalamic area; 
mah, mahogany; MC4-R, melanocortin 4 receptor; M C H , melanin-concentrating hormone; NPY. 
neuropeptide Y; O R X , orexin/hypocretin; P V N , paraventricular nucleus; V M H , ventromedial 
hypothalamus; Yl, N P Y receptor 1; Y5, N P Y receptor 5. 
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It must be noted that besides central regulation of energy homeostasis, a large 
body of work, too numerous to detail here, is currently being conducted on peripheral 
mechanisms involved in energy homeostasis. These include the study of genes involved 
in diabetes/glucose metabolism, adipogenesis, thermogenesis, and lipid metabolism 
(Havel, 2004; Lowell and Bachman, 2003; Nandi et al., 2004; Rangwala and Lazar, 
2000). Of course, many, if not all, of these peripheral modulators of energy homeostasis 
are also closely intertwined with the central neural circuit. 
Obesity research has advanced remarkably from the original theories postulated 
in the 1950s to the cloning of leptin and the numerous other candidate obesity genes. 
However, these recent advances have only left us with more questions as we try to 
understand this complex pathway and identify new targets in order to develop better 
therapeutics for perhaps the worst medical epidemic of our current time. 
Candidate gene search in the ventral medial nuclei of the hypothalamus 
We were interested in identifying new genes that are involved in the energy 
homeostatic pathway. The current literature suggested that the hypothalamus plays a 
key role. Therefore, a screen for hypothalamic genes regulating and regulated by the 
energy homeostatic pathway was developed. Gold thioglucose (GTG) was chosen to 
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chemically ablate these neurons. Genes in the neurons affected by G T G treatment were 
hypothesized to play a possible catabolic role in energy homeostasis. 
GTG is composed of a gold moiety attached covalently to glucose (Debons et al., 
1977). During an initial toxicological study when rodents were injected 
interperitoneally (i.p.) with GTG, the rodents subsequently became hyperphagic and 
morbidly obese (Brecher and Waxier, 1949). Sectioning of the mouse brain treated with 
GTG found distinct and reproducible damage primarily in the VMH (Marshall et al., 
1955). It was hypothesized that the glucose molecule was essential for the lesions 
caused by GTG. Chemicals similar to gold thiolglucose such as gold thiolgalactose and 
gold thiosorbitol failed to induce any lesions in the VMH (Mayer and Marshall, 1956). 
The effects of GTG could also be inhibited by prior treatment with sodium thioglucose or 
2-deoxy-D-glucose, neither of which damage the VMH but are glucose analogues 
(Likuski et al., 1967). Furthermore inhibitors of glucose transport such as phlorizin 
have been shown to block the effects of GTG (Debons et al., 1974). Finally, diabetic 
mice are protected from the effects of GTG until they are treated with insulin, which 
appears to restore the sensitivity of neurons to both glucose and GTG (Debons et al., 
1969; Debons et al., 1968). As the VMH has been found to be rich in glucose-receptive 
neurons, it was hypothesized that GTG caused lesions primarily in these 
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glucose-responsive neurons of the V M H . 
The VMH plays a key role in energy homeostasis. According to the "dual 
center" hypothesis mentioned briefly above, the VMH serves as a "satiety center" while 
the lateral hypothalamus serves as a "feeding center." This hypothesis arose from lesion 
studies such as those done with GTG. Electrolytic lesions of the VMH and the nearby 
arcuate nucleus caused a profound hyperphagia and obesity. Therefore, these 
hypothalamic nuclei were thought to control feeding impulses in a negative/catabolic 
manner. Additionally, glucose is known to activate VMH neurons, while it inhibits LH 
neurons (Oomura, 1983). Following the glucostatic theory proposed by Mayer, VMH 
has been classified as having glucose-receptive neurons that are activated when blood 
glucose levels are high leading to suppression of food intake. However, the role of the 
VMH and the hypothalamus has proven to be much more complex. While other 
hypothalamic nuclei involved in the energy homeostatic pathway have begun to be well 
characterized at a molecular level, the VMH has remained strangely devoid of any new 
findings. Strikingly, there have been no neuropeptides or neurotransmitters localized in 
the VMH that have shown strong and conclusive evidence for a role in energy 
homeostasis. The VMH does contain several receptors and thus may serve as a 
"receptive" center. 
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A former post-doctoral fellow in the laboratory, Hong Fei, conducted a search 
for hypothalamic genes involved in energy homeostasis. Fei used GTG to induce 
obesity in mice (Fei et al., 1997). Subtraction hybridization followed by a ribonuclease 
protection assay (RPA) was used to identify genes that may have been differentially 
regulated between GTG treated and wildtype mice. She found one clone whose RNA 
expression was down-regulated after GTG treatment and identified it as a putative orphan 
G-protein-coupled receptor (GPCR) (Figure 6). The gene was orthologous to a 
previously published human orphan GPCR, GPR7 (Figure 7a) (O'Dowd et al., 1995). In 
situ hybridization by Fei and from published works from others have established GPR7 to 
be in key hypothalamic nuclei and in other regions of the brain (Figure 8, data not shown) 
(Lee et al., 1999; O'Dowd et al., 1995). Specifically, in rodent brains, the gene has high 
expression levels in the following regions: hippocampus, hypothalamus, and midbrain. 
In the hypothalamus, GPR7 expression was found in the arcuate nucleus, ventromedial 
nucleus, paraventricular nucleus, and suprachiasmatic nucleus. All of the above 
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Figure 6) G T G causes obesity in mice and down-regulates hypothalamic G P R 7 expression. A ) Bod y 
weight gain in female C B A / J wildtype mice 4 weeks after a single i.p. injection of 2mg/g body weight 
G T G (control - empty circles; G T G - filled circles). B ) RN a s e Protection Assay on hypothalamic R N A 
after P B S and G T G injection. C ) Northern blot analysis of hypothalamic R N A after treatment with G T G . 
Lane 1 P B S Control, Lane 2 G T G injection with a body weight gain of less than 20g (failure to gain 
obesity), Lane 3 - G T G injection with a body weight gain greater than 20g (successful weight gain after 
G T G injection). 
G P R 7 . an intronless orphan G P C R , has some sequence similarities to other 
G P C R s . The same group that had initially identified G P R 7 also cloned another related 
GPCR, GPR8, by degenerate PCR in humans, rabbits, and monkeys but could not be 
isolated in rats or mice (O'Dowd et al., 1995). Furthermore, an analysis of published 
mouse genome sequence has revealed that G P R S in mice, at least, appears to be a 
pseudogene (data not shown). GPRS has 64% identical amino acids with GPR7 (Figure 
7a, b). GPR7 and GPR8 have the highest sequence similarities with the opioid receptors 
2S 
and somatostatin receptors ( 3 0 - 4 0 % a m i n o acid similarity). H o w e v e r , neither opioid 
and opioid-like ligands nor somatostatin have been shown to bind the receptor in a 
heterologous expression system with high affinity (O'Dowd et al., 1995; Tanaka et al., 
2003). This suggests that GPR7 is not an opioid receptor and has a different non-opioid 
peptide ligand. With the endogenous ligand still unknown at this point and the 
receptor's expression in key hypothalamic nuclei, GPR7 knockout mice were generated 
in order to elucidate the role of the receptor in vivo. 
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Figure 7 A ) A m i n o acid sequence alignment of G P R 7 and related receptors ( O ' D o w d et al., 1995). All are 
from human sequences except for partial mouse GPR7 sequence (mGPR7). Identical amino acids are 
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Figure 7B) G P R 7 (top) and G P R 8 (bottom) sequence alignments among different animal species (Lee et al., 
1999). GPR7 and GPR8 are from human. FL = flying lemur; TS = tree shrew; Rab = rabbit; Mus = 
mouse; Mon = monkey; Pro = lemur. Shaded and boxed regions are divergent from human sequence. 
Transmembrane regions are grouped together. Note that GPR8 orthologs have been cloned for many 
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Figure 8) G P R 7 m R N A distribution patterns in rat brain by in situ hybridization (Lee et al., 1999). Coronal 
rat brain sections presented rostrocaudally, showing in distance from bregma. (A) +1.7 m m . (B) mm. 
(C) -1.3 m m , (D) -1.8 m m , (E) -3.3 mm,and (F) -4.3 m m . Abbreviations are as follows: TT=taenia tecta, 
ICj=islands of Calleja, ICjM=major island of Calleja, PO=primary olfactory cortex, En=endopyriform 
nucleus, OT=olfactory tubercle, SO=supraoptic nucleus, SCN=suprachiasmatic nucleus, DG=dentate gyrus, 
CA=fields of Amnion's horn, PVN=paravcntricular nucleus, DMH=dorsomcdial nucleus, 
VMH=ventromedial nucleus, Arc=arcuate nucleus, PVT=periventricular nucleus of thalamus, MeA=medial 
amygdaloid nucleus, PmCA=posteromcdial amygdaloid nucleus. 
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G P R 7 Ligands - Neuropeptide B and Neuropeptide W 
While the GPR7 knockout mice were being analyzed, several groups 
independently identified the endogenous peptide ligands for GPR7 and its homolog 
GPR8 using reverse pharmacology and computational genomics techniques (Brezillon et 
al., 2003; Fujii et al., 2002; Shimomura et al., 2002; Tanaka et al., 2003). The ligands 
were named neuropeptide B (NPB) and neuropeptide W (NPW) (alternatively called by 
one group L7 and L8) and are formed from two distinct and novel genes that have no 
known homologies to other genes except for themselves. The genes encoding for NPB 
and NPW are similar to each other and are evolutionarily conserved from xenopus to 
zebrafish to mammals including rodents and primates (Figure 9). The NPB and NPW 
encoding genes are putatively thought to form a prepropeptide with a signal peptide 
cleavage site and a proteolytic processing site of a pair of dibasic arginines that can be 
cleaved to form NPB-23 and NPB-29 or NPW-23 and NPW-30 respectively for either a 
23 amino acid peptide or a 29/30 amino acid peptide. 
Both peptide ligands NPB and NPW can bind and activate GPR7 and GPR8 in 
nanomolar or subnanomolar concentrations (Figure 10). In order to test for the binding 
and activity of the ligands for GPR7 and GPR8, a xenopus melanophore assay, where 
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Figure 9) A m i n o acid sequences of N P B and N P W (Tanaka et al., 2003). (A) A m i n o acid sequences of 
mature NPB and NPW peptides. An asterisk indicates the posttranslational bromination site of the native 
bovine NPB. Peptide sequences of other species are deduced from cDNA sequences. Amino acid identities 
between NPB and NPW are shown in black. Shaded residues are conserved only within the NPB or NPW. 
(B) Deduced amino acid sequences of prepro-NPB and NPW precursor polypeptides. .Mature peptides arc 
marked by equal signs. Question marks indicate undetermined sequence of bovine prepro-NPB. Human and 
mouse prepro-NPW cDNA do not have a translation initiator ATG codon; putative translation initiation 
sites are indicated by a pound sign. An arrow indicates a possible additional processing site for NPW. 
Identical amino acids within the orthologues are shown in black. Lightly shaded residues are conserved in 
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Figure 10) In vitro pharmacology of N P B and N P W assessed by melanophore pigment aggregation assay 
(A and B) and [Ca*f]i transient assay (C) in mammalian cells (Tanaka et al., 2003). (A and B) X. laevis 
melanophores were transiently transfected with human GPR7 (A) or GPRS (B) cDNA, and challenged with 
various forms of synthetic human N P B and N P W peptides. Brominated N P B and nonbrominated N P B have 
approximately equal potencies on GPR7 (A), whereas both of them have much weaker potencies on GPRS 
(B). Brominated N P W and nonbrominated N P W both have similar potencies on G P R 7 and GPRS. 
des[L-Trp-l]NPB and des [L-Trp-1]NPW are both much less potent on GPR7 and GPRS. Data arc the mean 
of eight separate experiments. (C) Ltk- cells were stably cotransfected with the human GPR7 c D N A and 
Gqi chimera cDNA, and challenged with nonbrominated synthetic human N P B and N P W . N P B has a 
modestly higher potency than NPW. When Gqi c D N A is not cotransfected, neither N P B nor N P W could 
induce the calcium mobilization (open and filled circles are all overlapping). Peak [Ca:']i values are 
represented as percentages of the maximum response. Data are presented as the mean ± S E M of three 
experiments performed in duplicate. 
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Both synthetic N P B and N P W potently stimulated the aggregation of xenopus 
melanophores, a process known to involve Gj-coupled signaling pathways. In this assay, 
NPB appears to have a stronger affinity for GPR7 over GPR8 (EC50 of 0.2nM for GPR7 
and EC50 of 14nM for GPR8). On the other hand, NPW has equal affinity for GPR7 or 
GPR8 (EC50 of 0.56nM for GPR7 and EC50 of 0.5 InM for GPR8). In another study, 
Chinese hamster ovary (CHO) cells were transfected with either human GPR7 or GPR8 
(Shimomura et al., 2002). Synthetic NPB and NPW both potently and dose-dependently 
inhibited the cAMP accumulation induced by forskolin. This effect was abolished by 
preincubation with pertussis toxin. Both the xenopus melanophore and cAMP assays 
support that upon ligand binding and activity through either NPB or NPW, GPR7 and 
GPR8 signal by coupling with a G; protein. 
Interestingly, NPB that was purified from brain extracts was found to have a 
brominated C-6 L-tryptophan in the first amino acid position (Fujii et al., 2002; Tanaka et 
al., 2003). This brominated tryptophan was not found in NPW. Also, non-brominated 
tryptophan could not be appreciably found in any peptide fractions isolated from bovine 
hypothalamus indicating that the brominated form of NPB is the dominant endogenous 
form. The role of the brominated tryptophan is unclear as non-brominated NPB had 
similar binding affinities and activity for the receptors. Brominated tryptophan has been 
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reported in conotoxin peptides derived from marine snails, but this represents the first 
known bromination modification of an amino acid in non-marine animals (Craig et al., 
1997; Jimenez et al., 1997). It is possible that bromination of NPB helps in the stability 
of the neuropeptide or other function outside of ligand binding. 
Also, an unusual start codon or translation initiator site was found for both 
human and mouse prepro-NPW gene. Instead of a standard AUG methionine start 
codon, prepro-NPW starts with a CUG leucine start site (Tanaka et al, 2003). The 
sequence surrounding the CUG start site confirms to Kozak's rule. Furthermore, in vitro 
mutational results showed that both CUG and AUG start sites produced equal amounts of 
the prepro-NPW peptide. Therefore, CUG appears to be the natural start site for this 
gene. Interestingly, both porcine and rat prepro-NPW and all known sequences of 
prepro-NPB have a standard AUG start site (Shimomura et al., 2002; Tanaka et al., 2003). 
The significance of this CUG start codon for prepro-NPW is unknown. 
While both NPB and NPW were isolated from brain tissues, the ligands are 
expressed in both central and peripheral tissues (Tanaka et al., 2003). In situ 
hybridization of NPB and NPW in the mouse brain has localized the two ligands to 
different neuronal populations (Figure 11). NPB mRNA was detected in several distinct 
brain regions including the hippocampus, paraventricular hypothalamic nucleus, 
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Edinger-Westphal nucleus, motor and sensory root of the trigeminal nerve, locus 
coeruleus, among other areas (Tanaka et al., 2003). NPB had the highest expression in 
the Edinger-Westphal nucleus. NPW mRNA was less widespread in the mouse brain 
with highest mRNA levels detected in the periaqueductal gray matter, ventral tegmental 
area, Edinger-Westphal nucleus, and dorsal raphe nucleus (Tanaka et al., 2003). An 
Figure 11) In situ hybridization of NPB (A-H) and N P W (I-L) m R N A on mouse brain sections (Tanaka et 
al., 2003). (Scale bars are 300 um.) (A-H) N P B m R N A in mouse brain. CA1-3, CA1-3 field of 
hippocampus; LHb, lateral habcnular nucleus; PaMP, paraventricular hypothalamic nucleus medial 
parvicellular part; EW, E W nucleus; m5, motor root of the trigeminal nerve; s5, sensory root of the 
trigeminal nerve; LPBI, lateral parabrachial nucleus internal part; Me5, mesencephalic trigeminal nucleus; 
Sub CA, subcoeruleus nucleus upart; A5, noradrenergic cell group A5; LC, locus coeruleus; IOB, inferior 
olive subnuclcus B. (I-L) N P W m R N A in mouse brain. P A G periaqueductal gray matter; EW, E W nucleus; 
VTA, ventral tegmental area; DR, dorsal raphe nucleus; DRD, dorsal raphe nucleus dorsal part. 
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independent study using a polyclonal antibody raised against rat NPW-23 peptide showed 
immunoreactive cells in the paraventricular nucleus (mainly in the parvocellular division), 
supraoptic nucleus, accessory neurosecretory nuclei, dorsal and lateral hypothalamus, 
perifornical nucleus, arcuate nucleus, and anterior and posterior pituitary (Dun et al, 
2003). The different localization of NPW between the two studies could possibly be 
due to different techniques used, mRNA versus protein expression pattern. In 
periphery, NPB was highly expressed in stomach, spinal cord, and testis, while NPW 
expression was strongly detected in stomach and lung (Tanaka et al., 2003). The 
distinct expression patterns of NPB and NPW in the brain and periphery suggest separate 
physiological roles for the ligands even though both act on one common receptor GPR7 
in rodents or on two receptors, GPR7 and GPR8, in other mammals including humans. 
Pharamacological injections of the peptide ligands have a number of disparate 
effects on rodents. An ICV bolus injection of NPB at the onset of the dark phase 
initially elicits a small transient increase in food intake followed by a much larger, 
sustained suppression of food intake (Figure 12) (Tanaka et al., 2003). Synergistic 
decrease in feeding was seen when corticotropin releasing factor (CRF) was 
coadministered with NPB. In addition, locomotor activity was increased when NPW 
was injected into rats during either light or dark cycle (Tanaka et al., 2003). These data 
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suggest that N P B could b e acting pharmacologically as a centrally active catabolic factor. 
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Figure 12) In vivo pharmacological effects of i.c.v.-injected N P B on food intake (A and B) (Tanaka et al., 
2003). (A) Vehicle or 3 or 10 nmol of synthetic rat NPB was i.e.v. injected in bolus into freely fed mice, 
and food consumption was measured. Injections were performed at 20:00 (beginning of dark phase) and 
food intake was measured at 22:00, 00:00, and 08:00 the next morning (end of dark phase). The data 
represent food intake between the indicated times (mean ± SEM, n = 4-5 per group). (B) Anorexic effect of 
NPB is enhanced by pretreatment with CRF. CRF (0.3 nmol) was i.e.v. injected 15 min before the injection 
of 3 nmol of synthetic rat NPB in mice. NPB was i.e.v. injected at 20:00 (beginning of dark phase), and 
food intake was measured at 22:00 and 00:00. n.d., no food intake detected (bars invisible). The data 
represent food intake between designated times in dark phase (mean ± SEM, n = 7 per group). * indicate 
significant difference (P < 0.05, one-way ANOVA, Fisher's post hoc analysis). 
N P B and N P W have various other effects when centrally administered to rodents 
including enhancing analgesia and stimulating the release of prolactin and corticosterone 
but inhibiting the release of growth hormone (Baker et al., 2003; Shimomura et al., 2002; 
Tanaka et al., 2003). Analgesic activity for centrally administered NPB was seen only 
.V) 
in the formalin test and not by the thermal induced paw flick test (Tanaka et al., 2003). 
As the licking response in the formalin test is mainly believed to be due to a complex 
supraspinal behavior including both affective and motivational processing of nociception, 
this could represent a role for GPR7 signaling in supraspinal analgesia as opposed to 
inflammatory analgesia (Donahue et al., 2001). The control of prolactin, corticosterone, 
and growth hormone release by NPW suggest that GPR7 signaling has important 
neuroendocrine functions. These effects appear to be mediated through the 
hypothalamus as direct exogenous administration of NPW on dispersed, anterior pituitary 
cells, which also express GPR7, had no effect (Baker et al., 2003). The physiological 
relevance of any of these pharmacological effects is currently unknown. 
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Specific Aims 
This thesis aims to elucidate the physiological role of GPR7 signaling in 
mammals. GPR7 was initially identified as a candidate obesity gene from an earlier 
screen of GTG down-regulated hypothalamic genes. First, GPR7 knockout mice were 
generated by disrupting the single intronless coding region with a STOP-IRES-tau-EGFP 
cassette. These mice were analyzed for a variety of physiological and behavioral 
disturbances. The initial focus was on defining possible metabolic defects and any role 
it might play in common energy homeostasis signaling pathways such as leptin and 
melanocortin. Second, due to the observed metabolic defects in the GPR7 knockout 
mice, the localization and possible metabolic regulation of GPR7 and its ligands were 
explored. Third, further studies with the GPR7 knockout mice concentrated on defining 
potentially other behavioral phenotypes including anxiety, depression, sleep-wake cycles, 
and circadian rhythms. Feeding behavior is often associated with the same neural 
circuits involved in regulating other complex behaviors. Finally, a summary of the 
results of this current study with those in the literature elucidating the role of GPR7 and 
its ligands in mammalian physiology is presented along with directions for future studies. 
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Chapter 2: Materials and Methods 
Animal Care and Maintenance. Unless otherwise indicated, all mice were maintained 
under the following conditions. Mice were maintained under a strict 12 hour lightdark 
cycle (lights ON 7AM) in a temperature and humidity controlled room and fed ad libitum 
on a standard rat diet (Diet 5001 12% kcal fat, 23.5% kcal protein, 64.5% kcal 
carbohydrate or Diet 5053 - 12% kcal fat, 23.5% kcal protein, 64.5% kcal carbohydrate, 
Lab Diet) and filtered water. Mice were weaned at four weeks of age and group-housed 
(2 to 5 animals per cage) according to sex. All tail clipping for genotyping was done at 
time of weaning. All animal work was conducted in accordance with the guidelines of 
the Rockefeller University Laboratory Animal Research Center or the appropriate 
institutional review board. 
Targeted Disruption of GPR7. A stop codon-IRES-tau-EGFP-thymidine 
kinase-neomycin cassette was inserted into a unique StuI site in the coding sequence of a 
genomic clone of the GPR7 gene. 129/Ola embryonic stem (ES) cell line was 
transfected with linearized vector by electroporation. Transfected ES cells were 
screened by neomycin resistance and by Southern analysis of BamHI digested genomic 
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D N A to identify clones that had undergone successful homologous recombination. A 
heterozygote cell was expanded and thymidine kinase-neomycin was excised by cre 
recombinase. Correctly targeted ES clones were injected into blastocytes and implanted 
into pseudopregnant mice. Chimaeric mice were generated and bred to C57BL/6J 
female mice. 
Genotyping GPR7 knockout mice by Southern blotting. Successful germline 
transimission and all genotyping were confirmed by tail genomic DNA Southern analysis. 
Tail genomic DNAs were extracted in a lysis buffer [50mM Tris, pH 8; lOOmM EDTA; 
0.5% SDS] with freshly added proteinase K [350jag per tail] at 55°C with shaking 
overnight followed by a phenolxhloroform extraction, isopropanol precipitation, ethanol 
wash, and dissolved in an appropriate volume of ddFbO and stored at 4°C until use. The 
purified tail genomic DNAs were then digested overnight at 37°C with BamHI and were 
separated on a 0.8% agarose gel in TAE buffer (60-90V for 4 to 6 hours). The gel was 
washed for 30 minutes in denaturing solution (1.5M NaCl, 0.5M NaOH) at room 
temperature (RT) with mild shaking followed by 30 minutes in neutralizing solution 
(1.5M NaCl, 0.5M Tris-Cl, pH 8) at RT with mild shaking and then transferred to 
Hybond membrane (positive charged nylon membrane, Amersham) using 10XSSC (1.5M 
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NaCl, 0.15M sodium acetate) transfer buffer overnight. The blot was dismantled, and 
the membranes briefly rinsed in 10XSSC to remove excess agarose and dried at RT. 
The membranes were then UV auto-crosslinked with a Stratalinker (Stratagene). For 
hybridization studies, all membranes were prehybridized for at least two hours using 
RapidHyb buffer (Amersham) at 65°C. Hot 32P DNA probes were synthesized using 
PCR under the following conditions. The DNA probe template was a 220bp fragment 
approximately 440bp upstream of the ATG start site and was cloned from genomic DNA 
obtained from a wildtype C57BL/6J mouse. Forward primer: 5' CAC CTC TGC TGA 
ATT CGC 3'; Reverse primer: 5' TCC AAG GCT GGA GAC AGA 3'. PCR conditions 
used for both synthesis of cold DNA template and subsequent hot PCR amplification: 
95°C x 30 seconds, 55°C x 30 seconds, 72°C x 30 seconds for 35 cycles using a standard 
Perkin Elmer thermocycler. For the hot probe synthesis, dCTP was replaced with fresh 
a32P dCTP. 1,000,000 CPM/ml buffer was added to each membrane and hybridized at 
65°C for several hours (4-8 hours) or overnight (14-20 hours). Membranes were washed 
twice with 2XSSC, 0.1%SDS at 65°C for 15 minutes each followed by a more stringent 
wash at 0.1XSSC, 0.1%SDS at 65°C for 15 to 30 minutes. The membranes were then 
exposed to film (Kodak Biomax MS film) at -80°C overnight or to a Storage Phosphor 
screen (Amersham) at RT overnight. All Storage Phosphor screens were analyzed using 
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a Typhoon 9200 scanner (Amersham) and ImageQuant software version 5.2 (Molecular 
Devices). The recombinant band is 5kb in length, and the wildtype is approximately 
6.5kb. 
Generating and genotyping ob/ob and Ay/a GPR7 double mutant mice 
All GPR7 mutant mice used for breeding were backcrossed at least six generations to 
C57BL/6J mice (N6) unless otherwise noted. C57BL/6J ob/+ and Ay/a mice were 
purchased from Jackson Laboratories and mated to GPR7A- mice to generate C57BL/6J 
double heterozygote mice (ob/+ GPR7A- and Ay/a GPR7A-). All ob/ob GPR7 double 
mutants were offspring of double heterozygote crosses, while Ay/a GPR7 double mutants 
were generated with a double heterozygote male crossed to a GPR7+/- female mouse (i.e., 
ob/+ GPR7+/- x ob/+ GPR7+/- and Ay/a GPR7+/- x a/a GPR7A-). The ob gene was 
genotyped by PCR as previously described (Erickson et al., 1996b). Briefly, the 
following PCR primers were used to amplify a 247bp fragment of the ob gene. Forward 
primer: 5' GAC TTC ATT CCT GGG CTT CA 3'; Reverse primer: 5' TCT GTG GAG 
TAG AGT GAG GC 3'. 95°C x 45 seconds, 55°C x 45 seconds, 68°C x 1 minute and 30 
seconds for 40 cycles. The resulting PCR amplified DNA fragment of the ob gene was 
digested with Ddel at 37°C for 4 hours to overnight and analyzed on a 2% agarose gel. 
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The ob/ob mutation inserts an extra Ddel site into the ob gene yielding a 105bp, 47bp, 
and 32bp fragment from the amplified PCR DNA compared to only two fragments of 
152bp and 32bp in the wildtype mouse. Agouti mutation was selected by visual 
inspection for agouti fur coat color, which was transmitted as a dominant trait as 
expected. 
Body Weight, Food Intake, Metabolic Rate and Locomotor Activity Measurements. 
Body weights were measured once a week for group-housed mice except for mice fed a 
high fat diet (D12451 45% kcal fat, Research Diets), which were all single-caged and 
weighed weekly. Food intake was carefully measured in single caged animals with an 
acclimation period of at least one week before measurement. Energy expenditure and 
locomotor activity was measured using the Oxymax and OptoM3 system (Columbus 
Instruments). Air flow into the calorimeter sensors was set at 0.5L/min of room air with 
water in the air removed by passing the air through dehumidifier columns filled with 
magnesium perchlorate (Fisher). The O2 and CO2 sensors were calibrated with a known 
span gas (20.5% 02, 0.5% C02, 79% N2; TW Smith) before each test run. Mice were 
individually placed in the calorimeter chambers and stabilized for one day before 
measurements were recorded for two full days. Mice in the chambers had free access to 
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both standard rat diet and water. Locomotor activity was monitored every minute for 
each infrared beam break in the three planes (x, y, and z) for the 12 hour light and dark 
phases. Metabolic rate was considered as a "resting" value when the mice showed no 
movement in all three planes as recorded by infrared beam breaks lining the cage. 
Plasma and Body Composition Measurements and Liver Histology. Mice were 
sacrificed by C02 asphyxiation following a four hour fast during the light cycle (food 
removed 11:00AM, sacrificed 3:00PM). Blood was immediately collected by cardiac 
puncture using an EDTA-treated syringe needle. Plasma was obtained by centrifuging 
the blood and stored at -20°C or lower until further analysis. Glucose was analyzed by 
the glucose oxidase method using a commercial glucometer (Bayer). Insulin and leptin 
were measured by ELISA (Alpco, R&D respectively). Hypothalamus, whole brain, and 
a small piece of liver (~150mg) were removed and snap frozen in liquid N2 before body 
composition analysis of the same mouse. Body composition was analyzed as previously 
described by a chloroform:methanol biochemical extraction using a Soxhelt system 
(Cohen et al., 2001). The animal carcasses were dried in a 90°C oven until their weight 
remained constant (>2 weeks), and all the body water had evaporated. The difference in 
weight before and after drying was taken as total body water weight. The dried 
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carcasses were homogenized in a blender, and a lg extract was removed for lipid 
extraction. Lipids were extracted with boiling 3:1 chloroform:methanol solution for 
greater than 3 hours until no trace of lipids could be seen. The ratio of difference in the 
weight before and after lipid extraction was used to calculate lean and fat mass for each 
individual animal. All lipid extractions were carried out in duplicates. Liver histology 
was performed following standard hematoxylin and eosin staining techniques in paraffin 
embedded formaldehyde-fixed tissues. 
Fasting and refeeding response in GPR7-/- mice. Weight-matched adult male 
N10-C57BL/6J GPR7A mice and wildtype littermate controls (GPR7A+, n=7; GPR7-/-
n=6; age 30-38 weeks of age) were acclimated to single cage housing for several months 
(>4 months) prior to start of experiment. The initial body weight and baseline food 
intake was recorded 24 hours prior to start of fast. Food was removed for 24 hours 
(starting at 12PM - light cycle), while water was freely available throughout the whole 
study period. Standard rat chow was reintroduced after the 24 hour fast period. Body 
weight was recorded immediately following the fast (time 0) and 6, 24, and 48 hours after 
food was reintroduced. Food intake was monitored 1, 3, 6, 24 and 48 hours after food 
was reintroduced. 
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Glucoprivic Feeding Response in GPR7-/- Mice. N 6 or N10-C57BL/6J male G P R 7 A + 
and GPR7-/- mice between 33 and 44 weeks of age were acclimated to single cage 
housing for greater than 1 week. Mice were handled daily for a minimum of five 
consecutive days to minimize stress prior to i.p. injection of either sterile PBS or 
2-deoxy-D-glucose (500mg/kg body weight or 250mg/kg body weight, Sigma). 
2-deoxy-D-glucose was dissolved in sterile filtered PBS to make a lOOmg/ml or 
200mg/ml solution. Each mouse received no more than 100u.l of solution by i.p. Food 
intake was monitored immediately following each injection at 2, 4, and 5 hours 
post-injection. ICV injections of 2-deoxy-D-glucose followed procedures as given 
below. 
Cannulation of animals. N10-C57BL6J male mice between 20 to 24 weeks old were 
anesthesized with sodium pentobarbital (Nembutal, 50-60mg/kg body weight i.p.) and 
placed in a stereotaxic apparatus (Kopf Instruments). Guide cannulas with a threaded 
cylindrical plastic pedestal molded around a stainless steel tubing extending 1.5mm 
below the pedestal (Plastics One) were implanted 0.5mm posterior to bregma and 1.0mm 
lateral to the midline (Paxinos and Franklin, 2001). All guide cannulas were adhered to 
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the skull with cyanoacrylate gel (Loctite 454) and dental cement applied to the base of 
the pedestal. The mice were sutured to cover their surgical wounds and allowed to 
recover for a minimum of 10 days. Each surgery lasted less than one hour per mouse 
from induction of anesthesia to the end of suturing. During the recovery time, all mice 
were monitored daily for any signs of infection or loss of body weight and were 
extensively handled to minimize stress. 
ICV injections in GPR7-/- mice. O n the day of injection, the mice were moved to a 
procedure room in their home cages and allowed to acclimate to the room for two hours. 
During the acclimation period, all food was removed from the cages. All doses were 
delivered through an injector cannula projecting 1mm past the implanted guide cannula 
(Plastics One). The injector cannula was attached with PE50 tubing to a 25,ul gas-tight 
syringe (Hamilton). 2-deoxy-D-glucose (500rUg/ul) or sterile PBS was injected in a 
volume of 2,ul over a period of one minute followed by the needle remaining in position 
for an additional minute to ensure complete dispersal of the injected volume. Mice were 
returned to their home cage, where fresh pre-weighed standard rodent chow was 
immediately reintroduced. Food intake was monitored 2 and 4 hours after 
administration. Four to seven days passed between injections. 
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Ligand Binding and Activity in a Xenopus melanophore system. To test for ligand 
activity to mouse GPR7, a xenopus melanophore assay was used as previously reported 
(DeCamp et al., 2000; Tanaka et al., 2003). Mouse GPR7 cDNA was subcloned in 
pcDNA3.1 (+) expression vector (Invitrogen) and transfected into p\-l cell line of 
Xenopus melanophores. After 48 hours, absorbance at 650nm was measured before 
(Aj) and after 1 hour incubation with synthetic ligands (Af) with a 96 plate well reader 
(Molecular Devices). The equation 1-Af/A; was used to quantify melanosome 
aggregation, which is an index of Gj signaling (Lerner, 1994). 
RNA isolation and cDNA synthesis. Frozen tissues were homogenized with a polytron, 
and RNA was extracted using Trizol reagent (Invitrogen) following the manufacturer's 
protocol. Some RNA samples were enriched for polyA RNA by using Oligotex beads 
(Qiagen). After RNA was isolated from individual tissue, contaminating DNA was 
removed with DNase I (DNAfree, Ambion) followed by cDNA synthesis by reverse 
transcription using random hexamer priming (Applied Biosystems). 
Measurement of Gene Expression by Real-Time PCR. Quantitative real-time PCR from 
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hypothalamic c D N A was performed using the TaqMan® system analyzed with the ABI 
Prism 7700 Sequence Detection System using the Sequence Detection System software 
version 1.9.1 following the manufacturer's recommendations (Applied Biosystems). All 
expression data was normalized to cyclophilin expression levels from the same individual 
sample and carried out in duplicates. The reported results are relative values normalized 
to cyclophilin levels and are relative values compared to a standard curve based on 
wildtype brain or stomach expression levels unless otherwise noted. All primer and 
probe sequences were constructed using the Primer Express software (Applied 
Biosystems) using the specifications listed for the Taqman® assay system. Primer and 
probe sequences, labeled with 5'-FAM (except for cyclophilin labeled with 5'-VIC) and 

























Reverse Primer (5'-3') 







'All sequences are based on mouse sequences except M C H , which is from rat. 
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Northern blot analysis of gene expression. 1 % formaldehyde agarose gels were used to 
separate RNA for Northern blotting using standard techniques. 20u.g of total RNA or 
4|j.g of polyA enriched RNA were loaded into each lane. Ethidium bromide stained 28S 
rRNA bands from the gel before transfer was visualized by UV and quantitated using 
Multi-Analyst Software version 1.0.2 (Biorad). Each gel was washed in DEPC treated 
ddH20 for 15 minutes at RT with mild shaking followed by two washes in lOxSSC for 15 
minutes at RT with mild shaking. The RNA was then transferred by lOxSSC overnight 
to a positively charged nitrocellulose membrane (Hybond, Amersham). After 
dismantling the blot, it was quickly rinsed in lOxSSC to remove excess agarose and 
allowed to dry at RT before it was UV crosslinked (Stratalinker, Stratagene) and stored at 
-80°C until use. For hybridization of the blots, the blots were initially prehybridized in 
Ultrahyb (Ambion) at 42 to 45°C for 1 to 2 hours. Probe template cDNAs were 
synthesized by RT-PCR with primers listed below. Hot probe was synthesized by PCR 
as previously described, and l,000,000CPM/ml buffer was added. The probe was 
allowed to hybridize for 14 to 20 hours at 42 to 45°C. The blots were washed twice at 
42°C with a low stringency (2xSSC, 0.1%SDS) wash for 5 minutes each and twice at 
42°C with a higher stringency (O.lxSSC, 0.1%SDS) wash for 15 minutes each. After 
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the washes, the blot was exposed to film or a Storage Phosphor (Amersham) for analysis. 
Exposed Storage Phosphor cassettes were analyzed using a Typhoon 9200 scanner 
(Amersham) and Image Quant software version 5.2 (Molecular Devices). Median 
background was subtracted from each image before equal sized boxes of each band was 






















Differential gene regulation in altered feeding states. T w o separate age-matched groups 
(younger group 14 weeks old, older group 64 weeks old) of male C57BL/6J wildtype 
mice (Jackson Laboratories) were group-housed (five per cage) and had free access to 
standard rodent chow and water as described above. The fasted group had their food 
pellets removed for 48 hours, while the thirst group had the water bottles removed for 48 
hours. The refeeding group had food removed for 44 hours followed by a 4 hour 
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feeding period (during light cycle 11:00 and 15:00). After 4 hours, all mice in the 
refeeding group had stopped eating and were quietly sleeping with noticeably distended 
stomachs. Mice from each group were individually weighed at the start of experiment, 
24 hours later, and immediately before sacrifice. All mice were immediately sacrificed 
by C02 asphyxiation, blood drawn by cardiac perfusion, and tissues removed and frozen 
immediately in liquid nitrogen for future analysis. Plasma was separated from blood as 
previously described and stored at -80C with the tissue samples. 
Chronic Leptin Treatment. Female C57BL/6J ob/ob and control mice 8 weeks of age 
were purchased from Jackson Laboratories. Subcutaneous osmotic leptin pumps were 
implanted into mice as previously described (Soukas et al., 2000). Alzet 2002 
mini-osmotic pumps (Alza, Palo, Alto, CA) were filled with PBS or 400ng/ul leptin 
(Amgen, Thousand Oaks, CA) and incubated in sterile 0.9% NaCl overnight at 37°C. 
Mice were anesthetized with halothane, and the osmotic pumps were implanted 
subcutaneously. Pair-fed animals received the same amount of food eaten by the leptin 
treated group. Individual body weight and food intake were measured daily in each 
treatment group (PBS, leptin and pair-fed). jAnimals were sacrificed 2, 4, and 12 days 
after treatment. Plasma and tissues were collected as before and stored at -80°C until 
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use. 
Behavior Tests for G P R 7 Knockout Mice. All behavior tests were conducted either at 
Rockefeller University or University of Texas Southwestern Medical Center in Dallas. 
All procedures were approved by the appropriate institutional review board. For studies 
conducted at UT Southwestern, adult mice were shipped to the local animal facility from 
mice derived from the colonies maintained at Rockefeller University. All mice were 
acclimated to their new surroundings for a minimum of 6 weeks prior to any behavior 
tests. Studies at Rockefeller University were conducted in a behavior room separate 
from the animal colony rooms. All animals were exposed to the test conditions once 
unless specified below. Each test at Rockefeller University was videotaped by a camera 
positioned directly above the test field and scored offline blind to the genotype of the test 
animal. 
Sleep Recordings in G P R 7 Knockout Mice. Adult N10-C57BL/6J G P R 7 male mice 
(n=5 per genotype, 20-24 weeks of age, 28-30g at time of surgery) were implanted with 
custom lightweight EEG/EMG implants and cabling for chronic sleep activity monitoring. 
Custom EEG/EMG electrodes were made as detailed previously (Chemelli et al., 1999). 
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Briefly, the electrode was based on a six-pin double inline microcomputer connector 
(board mount socket 929 series from 3M, part number 929975-01-36) that was modified 
into a four-pin EEG electrode with each pin 1.3mm x 0.3mm (h x w) positioned 4.6mm x 
2.9mm (1 x w) apart with two EMG electrodes soldered to the center pins. The 
completed EEG/EMG electrodes were gold-plated by heating in a gold cyanide solution 
(Oromerse N Gold Solution; Technic Inc., Cranston, RI) at 70°C for two hours. Finally, 
the electrodes were sterilized in alcohol before implantation. 
All surgeries were conducted under standard sterile procedures. Mice were 
anesthesized with sodium pentobarbital (Nembutal, 50-60mg/kg i.p.) and placed in a 
stereotaxic apparatus (Kopf Instruments). The cranium was exposed and four small 
holes were drilled, anterior and posterior to bregma, bilaterally (AP 1.2mm, ML ± 
1.47mm and AP -3.5mm, ML ± 1.47mm) according to the atlas of Franklin and Paxinos 
(Paxinos and Franklin, 2001). The EEG/EMG electrode was then inserted into these 
four holes, cemented with dental acrylic (3m ESPE Ketac Cem Aplicap, 3M), and the 
EMG electrode was secured into the nuchal musculature. The EEG/EMG implantation 
technique described above allows for the precise and reproducible insertion of the 
electrodes that target bilaterally the frontal and occipital cortices at a defined and 
consistent depth, where the electrode is touching the dura with minimal trauma to 
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surrounding tissues. 
Following the implantation of the EEG/EMG electrodes, the mice were housed 
individually and the head-mounted connector was using a 15cm light weight cable to a 
slip ring commutator, which was suspended from a counter-balanced arm mounted to a 
standard rodent cage. This allows free movement of the tethered mice in the cage. 
Food and water was provided ad libitum. All mice were allowed to recover from 
surgery and habituated to these conditions for greater than ten days before recordings. 
For sleep monitoring, each mouse was recorded for three consecutive 24 hour periods, 
beginning at lights off at 19:00. Mice were not disturbed during this period except for 
daily checks of food and water at 19:00. All EEG/EMG signals were amplified using a 
Grass Model 78 (Grass Instruments, West Warwick, RI) and filtered (EEG: 0.3-100Hz, 
EMG:30-300Hz) before being digitized at a sampling rate of 250Hz, displayed on a 
custom paperless polygraph system, and archived to CD-R for offline sleep staging and 
analysis. Each EEG/EMG record was divided into 20 second epochs and visually 
scored as "Awake," "REM sleep," and "non-REM sleep" according to standard criteria 
for rodent sleep states (Rafulovacki 1984). Mice that had difficult or ambiguous 
EEG/EMG signals were ignored for final analysis (one mouse in each genotype). 
Differences between knockout mice and wildtype mice were analyzed using repeated 
58 
measurements A N O V A and student t-test as necessary (Graphpad Prism v4.00). 
Running Wheel Behavior. These studies were conducted at U T Southwestern. Adult 
N10-C57BL/6J female GPR7 mice (age 14-17 weeks) that were previously used for the 
open field tests (see details below) were placed in a running wheel system (Mimitter's 
Vital view system) and had free access to food and water. Eight total cages (4 per 
genotype) were run simultaneously. The mice were acclimated for a week on a 12 hour 
LD (lightdark) cycle. After the initial week of LD cycle running, another week of LD 
cycle was recorded before the light cycle was switched to a DD (dark:dark) cycle. All 
measurements were automatically recorded in 10 minute interval or bin sizes by the given 
software. Analysis was made offline. Tau (periods) were calculated using a freely 
available software program (http://www.circadian.org/softwar.html) based on the 
chi-square periodogram analysis procedure developed by Sokolove and Bushell (Refinetti, 
1993; Sokolove and Bushell, 1978). For the data collected for analysis, bin size was set 
at 10 minutes with a step set at 0.2. For each LD or DD cycle, 7 days of measurements 
were analyzed. 
Open Field Test. N10-C57BL/6J Male and female G P R 7 mice naive to the open field 
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apparatus were used. Two different apparatus were used for the studies. The initial 
studies were conducted on adult mice (13 to 19 weeks of age) at UT Southwestern. All 
mice were acclimated to the test room for at least two hours prior to the experiment. An 
Accuscan (Versamax) system was employed with an open field test apparatus of 36 X 
36cm in dimensions with 15 X 15 infrared beam arrays with 2.4cm interval. Each 
individual mouse was placed in the center of the test apparatus and allowed to freely 
move for 15 minutes. All tests were conducted during the light cycle (13:00 to 17:00). 
Two animals of each genotype were simultaneously tested. After each test, the animals 
were returned to their home cages, and the apparatus was thoroughly cleaned with 30% 
ethanol and dried completely before the next test run. Scoring was conducted 
automatically by the Accuscan system and analyzed offline. 
The second set of studies was conducted at Rockefeller University with adult 
mice 16 to 20 weeks of age essentially as described before (Romeo et al., 2003). On the 
day of testing the mice were transferred to the testing room and allowed to acclimate for 
at least two hours prior to the experiment. All tests were conducted during the animal's 
light cycle (13:00 to 17:00) and lasted for 15 minutes per animal. The open field test 
apparatus consisted of a 70 X 70 X 30cm field with a grid floor composing of 25 squares 
(16 outer and 9 inner) that were 14 X 14cm each. A single 150-W light bulb provided 
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illumination for the test. Each animal was singly placed in the same corner of the open 
field apparatus at the beginning of the test and allowed to freely move within the 
apparatus. The experimenter was not in the room during the duration of the test. At 
the end of the test, the animal was returned to its home cage, and the open field apparatus 
was thoroughly cleaned with 30% ethanol and dried to remove any trace of ethanol. 
Scoring for the test was conducted offline. All four paws had to cross the line of a 
center square to be considered an entry into the center of the open field. The overall 
testing environment between the two studies, Rockefeller University and UT 
Southwestern, were unfortunately not uniform with separate and different testing 
apparatuses and conditions. 
Elevated Plus Maze. The elevated plus maze tests were conducted in the same 
Rockefeller University behavior test room as with the open field tests during the light 
cycle (13:00 to 16:00) as described before (Romeo et al., 2003). The same animal from 
the open field tests were used two days after the open field tests and were naive to the 
elevated plus maze. The maze apparatus was 40.6cm above the floor and each arm of 
the plus maze was 64.77cm long and 5.08cm wide. The two closed arms have 22.86cm 
high black plastic walls. At the beginning of the test, each animal was placed in the 
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center of the elevated plus maze facing an open arm. All tests were conducted with the 
same illumination conditions as with the open field and were recorded for five minutes 
with the same videotaping setup with the experimenter outside the test room. At the end 
of each test, the animal was returned to its home cage, and the elevated plus maze was 
cleaned with 30% ethanol. Scoring was conducted offline blind to the genotype. All 
four paws had to cross the entry of the open or closed arm to be considered an entry. 
Porsolt Forced Swim Test. The Porsolt forced swim test was conducted essentially as 
previously described based on a modification of the original forced swim test (Lucki, 
1997; Lucki et al., 2001; Porsolt et al, 1977a) Adult N10-C57BL/6J male GPR7 mice 
(n=5-8 per genotype) 18 to 22 weeks of age were acclimated to the behavior test room for 
at least two hours prior to testing. A 4 liter cylinder (17cm diameter, Nalgene) was 
filled to a depth of 17cm with tap water that was acclimated to room temperature 
overnight. Videotaping was conducted in a similar fashion as previous behavior 
experiments. The observer was in the same room behind an opaque screen monitoring 
the mouse in the order to observe for any sign of overt distress while in the water cylinder. 
The first swim test was performed with the male mice group housed with their littermates. 
The second test was performed with the identical set of mice after four weeks of single 
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cage isolation. For each test, the mouse was individually placed into the swim cylinder. 
The videotape was set to record for fifteen minutes. After each swim, the mouse was 
placed into a clean cage and allowed to dry itself. The water in the swim cylinder was 
replaced and cleaned as needed. Analysis of the tapes was made offline. The first two 
minutes for each swim test was ignored and the next four minutes were observed for time 
of immobility. Immobility of the mouse was defined as when a mouse makes only the 
minimal movements needed to keep the head afloat. 
Statistics. All values are reported as means ± s.e.m. Results were analyzed by 
unpaired Student's t-test for comparison of two means or ANOVA followed by analysis 
using Tukey's or Dunnet's post-test for comparisons of three or more means (Prism 
version 4.00 for Windows, GraphPad Software, San Diego, CA). P values less than 
0.05 were considered as significant. 
Fried Ginger Chicken Recipe. All recipes have been approved by the Taste Buds of 
Higher Eating. Cut skinless, boneless chicken thighs (free range chicken, not Purdue) to 
bite-size pieces. Marinate overnight (or greater than 30 minutes) in special sauce at 4°C. 
Special sauce was made with 1 part soy sauce (Kikkoman or equivalent); 0.5-1 part mirin 
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(alternatively sake with sugar added) and ginger juice to taste. Ginger juice was 
extracted from freshly grated gingers (peel skin from ginger before grating). Pat dry 
marinated chicken thighs with paper towel and cover with corn starch (pat down lightly 
but remove any excess starch). Heat vegetable oil (Crisco or equivalent) in frying pan 
to medium temperature (170-180°C). Deep fry for 2-3 minutes until chicken turns 
golden brown. Sprinkle with sea salt while still hot and serve. Garnish with lemon 
slice if desired. 
Miso flavored Eggplant and Peppers. Prepare miso sauce by bringing 150ml mirin and 
0.5 to 1.5 part sake to boil for 20 seconds to evaporate alcohol. Turn heat down to low 
and add 450g miso paste (use white for a lighter taste, red for stronger) and mix with 
wooden spoon until paste dissolves. Constantly mix with spoon to prevent miso from 
burning. Add granulated sugar (225g) to miso paste while mixing. Turn heat off when 
sugar has completely dissolved and allow to cool to RT. Wash and cut vegetables 
(Japanese eggplant, yellow onions, green and red bell peppers) to appropriate size (I 
prefer lengthwise slices of about 2 to 4cm each). After making sure vegetables are dry 
marinate in the miso sauce for 20 minutes or longer at 4°C or RT. Heat cooking oil (use 
vegetable or sesame oil) in wok and stir-fry vegetables to taste. 
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Chapter 3: Results 
Gene Targeting Strategy. The following gene targeting strategy was adopted (Figure 
13a). An Internal Ribosomal Entry Site (IRES) followed by a tau-Enhanced Green 
Fluorescent Protein (EGFP) cassette was introduced into the mouse genomic sequence of 
GPR7 to disrupt the sequence. Specifically, the insertion was in the putative third 
transmembrane region (amino acid 112) of the orphan GPCR. Directly upstream of the 
insertion of the cassette a STOP codon was also placed. The IRES-tau-EGFP knock-in 
GPR7 knockout strategy should result in disruption of the gene as well as EGFP labeling 
of neurons that would normally express GPR7. A similar strategy was adopted in the 
knockout of the neuropeptide Y Y2 receptor by Naveilhan et al. (Naveilhan et al., 1999). 
Instead of EGFP labeling, their cassette for disruption was IRES-tau-LacZ. This group 
was able to successfully knockout gene expression of NPY Y2 receptor and to identify 
neurons normally expressing Y2 receptor by immunohistochemistry. With the targeting 
construct finished, we proceeded to inject the construct into 129/Ola ES cells using 
standard homologous recombination techniques to generate a chimeric mouse. Four 
chimeric mice were generated, and one founder line was generated with successful germ 
line transmission. 
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Generation of G P R 7 - / - Mice. Genotype was determined by Southern blotting of tail 
genomic DNA (Figure 13b). An intercross between heterozygote littermates produced 
wildtype (+/+), heterozygote (+/-), and knockout (-/-) mice in Mendelian ratios. 
Northern analysis and quantitative R T - P C R of hypothalamus from GPR7-/- mice 
confirmed a lack of full length intact GPR7 RNA (Figure 13c-d). Mice were initially 
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Figure 13) Gene targeting strategy and confirmation of GPR7 deletion. A) Map of gene targeting strategy 
for insertion of IRES-tau-GFP cassette into mouse GPR7. B) Tail genomic DNA Southern blot of 
heterozygous brother-sister mating (6.5kb is wildtype band; 5kb is recombinant band). C) Northern blot 
of hypothalamic and brain RNA for GPR7 (4kb is wildtype transcript; 6kb is transcript with insertion). 
GPR7 Northern probe targeted upstream of insertion site. D) GPR7 Taqman® real-time RT-PCR analysis 
of hypothalami from adult male GPR7+/+, +/-. and -/- mice (n=6/group). Taqman® GPR7 probe spanned 
insertion site. * denotes p<0.05 compared to GPR7+/+ levels. 
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phenotypic analysis, mice were backcrossed to C57BL/6J mice for six or more 
generations unless otherwise noted. The phenotypic differences seen in the GPR7-/-
mice between the mixed 12901a/BL6 strain and the C57BL/6J strain are minimal, and 
both strains showed essentially the same metabolic phenotype when studied until one 
year of age. 
Effect of G P R 7 Disruption on Body Weight and Composition. GPR7-/- mice were 
viable, fertile, and showed no gross abnormalities from birth to weaning. By 10 weeks 
of age, a significant increase in body weight (25.4±0.4g +/+ versus 26.9±0.4g -/-, p<0.05) 
was evident in the N6-C57BL/6J male GPR7-/- mice (Figure 14). This increase in body 
weight was evident throughout adulthood and was even more pronounced by 52 weeks of 
age (37.1±1.2g +/+ versus 42.5±1.9g -/-, p<0.05) (Figure 14b and Figure 15). 
Furthermore, when the mice were fed a high fat diet (45% kcal fat), the difference was 
markedly increased and also evident at an earlier age (29.4±0.5g +/+ versus 35.8±1.4g -/-
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Figure 14) Body weight curves of male GPR7 mice (a-c) and female GPR7 mice (d-f). Mice are either N3 
(52 week old mice only) or N6-C57BL/6J (b-c, e-f) or mixed 12901a/BL6 (a, d) fed a standard low-fat diet 
(a-b, d-e) or a high fat diet (c, 0- n>6 for all genotypes in all groups. p<0.05 from 10 to 52 weeks all 
male on low fat diet, 6-12, 17-32 weeks for high fat diet. p>0.05 for all female mice. 
Body composition w a s evaluated by carcass analysis of mice at 24 and 52 weeks 
of age fed a low fat diet. At 24 weeks of age, there was a trend towards higher total 
body lipid mass in male GPR7A mice (Figure 16c, Table 2). At 52 weeks of age, the 
total body lipid mass in male GPR7-/- mice was double that of GPR7+/+ mice with 
G P R 7 A - mice having an intermediate phenotype (5.83±0.74g +/+ versus 11.25±1.26g -/-. 
p<0.05; Figure 16d, Table 2). Full gross and histological necropsy studies were 
conducted on a set of older adult male GPR7-/- mice on the original 129/BL6 strain and 
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the N3-C57BL/6J strain. At necropsy, a pale enlarged liver was evident in the 129/BL6 
and the N3-C57BL/6J GPR7-/- male mice. Liver histology showed large vacuoles 
throughout the entire liver section consistent with severe hepatic steatosis (Figure 17c, d). 
Hepatic steatosis or fatty liver is a clinicopathologic syndrome that is commonly 
associated with obesity and the metabolic syndrome (Angulo, 2002). While there was a 
dramatic fat accumulation throughout many tissues including the grossly fatty livers and 
increased amounts of subcutaneous fat, there were no other gross histological 
abnormalities in all the major organs investigated (Figure 17). 
-/- +/+ 
Figure 15) Gross necropsy of representative 52 week old male N3-B16 GPR7+/+ and GPR7-/- littennates. 
No obvious abnormalities or lesions were detected except for an increase in general adiposity and an 
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Fig 16) B o d y composition analysis of G P R 7 mice. A - B ) 40 w e e k old adult male (A) and female (B) 
GPR7 mice from the original 12901a/BL6 strain. Male GPR7-/- mice had a significant increase in total 
lipid mass compared to GPR7+/+ litteimates (p<0.05). Female GPR7-/- mice had a statistically 
insignificant trend towards increased adiposity. C) 24 week old male GPR7-/- mice (N6-C57BL6/J) had a 
slight trend towards increased adiposity compared to GPR7+/+ littermates. D) 52 week old male GPR7-/-
mice (N3-C57BL6/J) had a significantly increased total lipid mass compared to GPR7+/+ littermates. 
This was similar in magnitude to the adiposity seen in the mixed 12901a/BL6 strain. 
















11.45 ± 1.24 
26.69 ±0.41 
61.86 ± 1.11 
52 week old Male GPR7 Mice 
+/+(9) 
16.92 ± 1.77 
26.12 ±0.78 
56.96 ± 1.64 
+/-07) 
21.89 ± 2.19 
24.22 ±0.88 
53.89 ± 1.58 
-/- (11) 
26.75 ±2.15* 
24.17 ± 1.07 
49.07 ± 1.32" 
* denotes a significant difference compared to same age GPR7±/± littermate controls. Number of animals 
in each genotype group is designated in parentheses. 24 week old mice are N6-C57BL/6J, while 52 week 
old mice are N3-C57BL/6J mice. 
70 
m 
• * m S n r 
Figure 17) Increased fat acclimation in tissues and hepatic steatosis in older male GPR7-/- mice. All 
sections were from formaldehyde treated samples that were stained with H&E. A-B) Tissue surrounding 
sternum with increased fat acclimation in GPR7-/- mice (B). Magnification lOOx (A-B). C-D) Liver 
sections showing hepatic steatosis in GPR7-/- mice (D). Magnification 200x (C-D). 
While these metabolic abnormalities were readily evident in the male GPR7-/-
mice, the female GPR7-/- mice had at best a mixed phenotype. Initially, 129/BL6 
mixed female GPR7-/- mice did show a trend towards an increase in body weight and fat 
mass similar to male GPR7A mice (Figure 14d, Figure 16b). However, female GPR7-/-
mice did not show any significant differences in body weight or fat mass when fed a low 
or high fat diet once on a pure C57BL6/J background (Figure 14e-f). 
71 
Metabolic Defects: Food Intake, Metabolic Rate and Locomotor Activity. W e next 
investigated the energy intake and output in adult male GPR7 mice. Food intake in 24 
week old male GPR7-/- mice was consistently increased by 10% compared to GPR7A+ 
littermates (Figure 18). Male GPR7-/- mice on a regular diet had decreased resting 
oxygen consumption (3,260±116ml/kg/hr +/+ versus 2,860±80ml/kg/hr -/-, p<0.05; 
Figure 19a), decreased carbon dioxide production (2,800±133ml/kg/hr +/+ versus 
2,350±83 ml/kg/hr -/-, p<0.05; Figure 19b), and decreased spontaneous locomotor 
activity during the dark cycle (12 hour dark cycle: 29,100±2,390 beam breaks +/+ versus 
20,900±2,310 beam breaks -/-, p<0.05 ; Figure 20a, b). The combination of 
hyperphagia and decreased energy expenditure, possibly in part due to decreased 
spontaneous locomotor activity, is a likely cause of the adult-onset obesity seen in the 
GPR7-/- male mice. Female GPR7-/- mice showed a slight statistically insignificant 
trend towards an increase in metabolic rate when compared to GPR7+/+ littermates 
(resting V02: 3,650±200 ml/kg/hr +/+ versus 4,100±140 ml/kg/hr -/-; p>0.05; resting 
VC02: 3,200±710 ml/kg/hr +1+ versus 3,700±390 ml/kg/hr -/-; p>0.05; Figure 19c, d). 
Female GPR7-/- mice did show a similar trend of decreased spontaneous locmotor 
activity (12 hour dark cycle: 61,500±18,500 beam breaks +/+ versus 46,800± 12,000 
beam breaks -/-, p>0.05; Figure 20c, d) as seen with male GPR7-/- mice. 
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Figure 18) Food intake of adult male G P R 7 mice. 24 week old mice were individually caged for greater 
than four weeks before weekly food intake of regular rodent chow was measured. Food intake was 
measured at least on four different occasions with two different sets of male mice. Representative data is 
shown here. * denotes p<0.05 compared to GPR7+/+ littermates. 
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Figure 19) Resting metabolic rate for adult N6-C57BL/6J G P R 7 mice on a standard low-fat rodent chow. 
Data is an average of a 24 hour cycle. A-B) Adult male mice 24 weeks old. C-D) Adult female mice 24 
weeks old. * denotes a significant difference compared to GPR7+/+ mice (p<0.05). Male GPR7-/- mice 
had significantly decreased resting V O : and V C 0 2 even when normalized for lean body mass only (data not 
shown). 
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Figure 20) Locomotor activity for N6-C57BL/6J G P R 7 Mice. A-B) Spontaneous locomotor activity for 
24 week old male G P R 7 mice during a 12 hour dark cycle (A) and 12 hour light cycle (B). * denotes 
significant difference when compared to GPR7±/± mice. C-D) Spontaneous locomotor activity for 24 
week old female G P R 7 mice during a 12 hour dark cycle (C) and 12 hour light cycle (D). A trend towards 
decreased locomotor activity was seen for female GPR7-/- mice, but no significant differences were seen 
between the female groups at either dark or light cycle. 
Plasma Values in GPR7-/- Mice. Analysis of plasma from 24 week old male mice on a 
regular diet showed normal glucose levels but a slight increase in insulin and a trend 
towards higher leptin levels in GPR7-/- mice (Table 3). By 52 weeks of age, GPR7-/-
mice were hyperglycemic and remained hyperinsulinemic (Tabic 3). The older male 
GPR7-/- mice were also significantly hyperleptincmic. Leptin levels are highly 
correlated with percent body fat in mammals (Maffei et al., 1995). When the plasma 
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leptin levels were compared to percent body fat in male GPR7-/- mice, they were found 
to have the same linear relationship as the GPR7+/+ mice (Figure 21). No significant 
differences were seen in the plasma levels of 52 week old female mice (Table 3). 





































































Student's unpaired t-test: * p<0.05 versus +/+; * p<0.005 versus +/+; ' p<0.10 versus +/+; Differences not 
statistically significant unless noted. n=5-ll for each group. 52 week old mice are N3-C57BL/6J. 
100 
10 
• 52 wks old GPR7 +/+ n=8 
x 52 wks old GPR7-/-n=11 
a 24 wks old GPR7 +/+ n=8 
* 24wks old GPR7-/- n=8 
10 15 20 25 
% Body Fat 
30 35 40 
Figure 21) Linear relationship between plasma leptin levels and body fat percentage in male GPR7 mice. 
Adult male mice of 24 and 52 weeks of age had similar linear relationship between leptin and body fat 
regardless of genotype. Data was analyzed by bivariate linear regressions assuming two-sided normal 
distribution of all data using the software program Stata. 
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Fasting-induced Feeding Response in G P R 7 - / - mice. A s G P R 7 signaling appears to 
be a "satiety" signal with mice lacking functional GPR7 becoming hyperphagic and 
obese, the response to fasting-induced refeeding was measured in GPR7-/- mice. 30 to 
38 w e e k old male G P R 7 + / + and GPR7-/- mice were fasted for 24 hours (beginning at 
12:00) before reintroduction of food. GPR7-/- mice significantly ate more food after the 
24 hour fast than G P R 7 + / + mice in the short and long term (Figure 22). This 
overcompensation was seen even though the two groups were matched for their body 
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Figure 22) Feeding response of adult male GPR7 mice after a 24 hour fast (n=7 for GPR7±/±; n=6 for 
GPR7-/-). A) Percent body weight change after 24 hour fast. All mice were matched for their weights 
before the experiment. No significant difference between the groups was seen at all time points measured. 
B) Food intake during first few hours after the 24 hour fast. GPR7-/- mice ate significantly more food 
than GPR7±/+ shortly after food was reintroduced. C) Food intake after 24 and 48 hours after the fast. 
GPR7-/- mice continued to slightly cat significantly more than GPR7±/± mice. 
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Glucoprivic Feeding in GPR7-/- Mice - 2-deoxy-D-glucose. With the abnormal 
response to fasting-induced feeding, adult male GPR7-/- mice's feeding response to 
decreased glucose utilization or glucoprivation was investigated by administering 
2-deoxy-D-glucose (2DG). 2DG is a glucose analog that acts as a specific inhibitor of 
intracellular glucose utilization by directly inhibiting phosphohexose isomerase, which 
leads to a reduction in glycolysis, in brain, muscle, liver, and other tissues (Brown, 1962; 
Horton et al., 1973). Administration of 2DG to mammals leads to an increase in blood 
glucose levels and a robust feeding response (Smith and Epstein, 1969). This feeding 
response to 2DG persists even after the centrally mediated sympathoadrenal 
hyperglycemia subsides (Ritter et al., 1978). Furthermore, the effects of glucoprivation 
are centrally mediated as doses too low to have an effect peripherally will have an effect 
when injected into the lateral ventricles (Miselis and Epstein, 1975). 
Adult male GPR7 mice were initially peripherally injected with a dose 
(500mg/kg body weight) known to elicit a robust glucoprivic feeding response in rodents. 
All mice at this dose regardless of genotype became obtunded and fell into a stupor. 
They remained in this stupor for up to 90 minutes after which they recovered without any 
long lasting ill effects. Glucoprivic induced feeding at this dose of 2DG was 
confounded by this stupor as GPR7+/+ failed to show an increase in feeding after 2DG 
77 
administration (Figure 23a). Another group of animals were tested using a lower but 
still effective dose of 2 D G (250mg/kg body weight). At this lower dose of 2 D G no 
mice b e c a m e obtunded, and both G P R 7 + / + and GPR7-/- mice displayed a normal 
response to glucoprivation (Figure 23b). Furthermore, central administration of 2 D G 
also resulted in a normal glucoprivic feeding response in both G P R 7 + / + and GPR7-/-
micc. Therefore, GPR7 signaling is not critical for feeding after a decrease in central 
glucose utilization. 
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Figure 23) Response to glucoprivation by 2-deoxy-D-glucose in male GPR7 mice. A) Feeding response 
after a peripheral injection of 500mg 2DG/kg body weight. All mice became obtunded. B) Both 
GPR7+/+ and GPR7-/- mice showed a similar robust increase in feeding after peripheral injection of a 
lower dose of 2DG (250mg/kg body weight) C) Feeding response to a single bolus ICV injection of 2DG 
(ling/animal). Both GPR7+/+ and GPR7-/- mice had an increase in food intake. * denotes p<0.05 and 
f denotes p<0.1. 
Hypothalamic Neuropeptide Levels in G P R 7 - / - Mice. To explore the possible role of 
the adipocyte hormone leptin in the pathogenesis of the obesity in male GPR7-/- mice, 
we measured whole hypothalamic RNA levels of NPY and POMC using real time 
quantitative RT-PCR. Leptin is secreted from adipocytes into the blood stream and acts 
directly on the hypothalamus, where it reduces neuropeptide Y (NPY) expression and 
activates proopiomelanocortin (POMC) expression (Elmquist et al., 1999; Friedman and 
Halaas, 1998; Zhang et al., 1994). In contrast to leptin deficient ob/ob mice, which have 
increased NPY levels and decreased POMC levels, NPY levels were decreased and 
POMC levels were increased in GPR7-/- male mice (Figure 24a, b). Levels of MCH, an 
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orexigenic signal that is thought to be downstream of N P Y and P O M C , but still part of 
the leptin-regulated pathway, were identical in the GPR7+/+ and GPR7-/- mice (Figure 
24c) (Qu et al., 1996). These data suggest that the mechanism underlying obesity in 
GPR7-/- mice is different from that evident in leptin deficient mice and that the NPY and 
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Figure 24) Hypothalamic neuropeptide expression levels in 24 week old N6-C57B1/6J male GPR7 mice. 
Taqman® real-time RT-PCR was used to determine levels of N P Y (A), P O M C (B), and M C H (C) in 
hypothalami of adult male G P R 7 mice. All data have been normalized to the cyclophilin levels and are 
shown as relative values compared to GPR7+/+ levels. * denotes a significant difference between 
GPR7-/- and GPR7+/+ mice. 
When expression levels for hypothalamic neuropeptides were investigated in 
older 52 week old adult male or female GPR7 mice, there was no change for either NPY 
or POMC levels (Figure 25). This lack of a coordinated compensatory response of 
decreasing NPY and increasing POMC levels seen in the younger male GPR7-/- mice 
could also account for the obesity seen in the older male GPR7-/- mice. 
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Figure 25) Hypothalamic levels of N P Y and P O M C in 52 week old N3-C57BL/6J GPR7 Mice. Taqman® 
real time RT-PCR was used to measure levels of NPY (A) and P O M C (B-C) in 52 week old male (A-B) and 
female mice. By 52 weeks, all male GPR7-/- mice were significantly heavier with increased adipositly 
and hyperleptinemia. No significant difference seen in any group compared to GPR7+/t littermate 
control levels. 
Body Weights and Metabolic Activity of ob/ob GPR7-/- and Ay/a GPR7-/- Mice. In 
order to establish whether the effect of a GPR7 mutation was independent of the 
orexigenic pathways activated by leptin deficiency, double mutant ob/ob GPR7-/- mice 
were generated. The male double mutants (ob/ob GPR7-/-) were more obese than 
standard ob/ob mice (16 weeks of age: 55.3±l.lg ob/ob +/+ versus 60.0±l.lg ob/ob -/-. 
p<0.05; Figure 26a), while female double mutant mice weighed the same as normal ob/ob 
female mice at all ages (Figure 26b). Lethal yellow Agouti (Ay/a) mice, which have 
deficient melanocortin signaling, were also mated to generate Ay/a GPR7-/- mice (Cone, 
1999). Similar to the ob/ob GPR7-/- animals, the male Ay/a GPR7-/- mice were more 
obese than standard Ay/a male mice (16 weeks of age: 38.6±l.lg Ay/a GPR7+/+ versus 
42.3±0.6g Ay/a GPR7-/-. p<0.05; Figure 26c), while female Ay/a GPR7-/- mice again had 
similar body weights to female Ay/a GPR7+/+ mice (data not shown). Furthermore, 
male Ay/a G P R 7 A mice ate significantly more food compared to male Ay/a GPR7+/+ 
mice (Figure 26d) but showed only a modest non-significant decrease in resting 
metabolic activity (V02: 2860±130ml/kg/hr Ay/a GPR7+/+ versus 2590±120ml/kg/hr Ay 
GPR7-/-; Figure 27a, b) and locomotor activity (12hr dark cycle: 17900±3440 beam 
breaks Ay/a GPR7+/+ versus 15900±1500 beam breaks Ay/a GPR7-/-; Figure 27c, d). 
The resting metabolic rate and locomotor activity was significantly decreased when Ay/a 
GPR7A+ mice were compared to wildtype (a/a GPR7+/+) mice (Figure 27c). These 
data strongly suggest that GPR7 affects energy homeostasis by a novel mechanism 
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Figure 26 A-B) Body weight curve for ob/ob G P R 7 mice. A ) Body weight curve of male ob/ob G P R 7 
mice. Male ob/ob GPR7-/- weighed significantly more than ob/ob GPR7+/+ mice (p<0.05). B) Body 
weight curve of female ob/ob G P R 7 mice. Female ob/ob GPR7-/- had similar body weights when 
compared to littermate ob/ob mice. p<0.05 for all male ob/ob GPR7-/- from 8 to 16 weeks of age when 
compared to ob/ob GPR7+/+ mice. 
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Figure 26 C - D ) B o d y weight and food intake of double Ay/a G P R 7 mice. C ) B o d y weight curve of adult 
Ay/a G P R 7 mice. Male Ay/a GPR7-/- mice weighed significantly more than Ay/a G P R 7 + / + mice (p<0.05). 
D ) Food intake in male Ay/a G P R 7 mice. Male Ay/a GPR7-/- mice ate significantly more than Ay/a 
G P R 7 + / + mice (p<0.05, n=4-6 in all groups). p<0.05 for all body weights of male Ay/a GPR7-/- mice 
from 8 to 16 weeks of age. 
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Figure 27) Metabolic and locomotor activity of 24 week old male Ay/a G P R 7 mice. A ) Resting oxygen 
consumption (V02) of Ay/a G P R 7 mice. B) Resting carbon dioxide production (VCO;) of Ay/a G P R 7 
mice. C-D) Locomotor activity comparison of a/a G P R 7 and Ay/a G P R 7 mice during the 12 hour dark 
cycle (C) and 12 hour light cycle (D). N o significant difference for all data. 
83 
Ligand Activity and Binding Data to Mouse GPR7 
The endogenous ligands for GPR7 have been recently identified by reverse 
pharmacology (Fujii et al., 2002; Shimomura et al., 2002; Tanaka et al., 2003). In these 
previous reports, the pharamacological studies used non-rodent samples to isolate and test 
the ligand binding and activity to GPR7 and GPR8. To determine whether the ligands 
for GPR7, NPB and NPW, posses the same activity and binding characteristics on mouse 
GPR7, a xenopus melanophore assay identical to one conducted for human GPR7 and 
GPR8 was conducted using cells transfected with the full coding sequence from the 
cloned mouse GPR7 gene (Tanaka et al., 2003). The cells transfected with mouse 
GPR7 had identical dose response curves to NPB and NPW when compared to cells 
transfected with human GPR7 (Figure 28). Therefore, as expected, the cloned mouse 
sequence is the definitive mouse GPR7 sequence and is the endogenous receptor for the 
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Figure 28) Xenopus melanophore assay for ligand binding to mouse GPR7. The assay was performed 
essentially as described before (Tanaka et al., 2003). N PB had a higher affinity for GPR7 (both human 
and mouse) compared to N P W . hGPR7 = human GPR7; m G P R 7 = mouse GPR7; mel = melanosome 
positive control reaction. 
Tissue Distribution of G P R 7 and its ligands, N P B and N P W 
G P R 7 was initially cloned and found to have high R N A levels in various discrete 
areas of the rodent brain and the pituitary gland (O'Dowd et al., 1995). The ligands for 
G P R 7 were also isolated from the brain of various species (Fujii et al., 2002; Shimomura 
et al., 2002; Tanaka et al., 2003). The gene expression profile of G P R 7 and its ligands 
in other tissues outside the central nervous system in mice was explored. Select tissue 
R N A was isolated from adult male wildtype C57BL6/J mice, and gene expression of 
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G P R 7 and its ligands N P B and N P W were analyzed by real time RT-PCR. G P R 7 was 
expressed at appreciable levels only in neuronal tissues including hypothalamus and the 
spinal cord (Figure 29a). Very low levels were also seen in the stomach, lungs, and 
testis but not in the other peripheral tissues examined. These levels were only slightly 
above background levels, and their physiological relevance is unknown. For the GPR7 
ligands NPB and NPW, high levels of gene expression were seen in the CNS as well as in 
peripheral tissues (Figure 29b, c). NPB had the highest levels in the spinal cord 
followed by testis, stomach and spleen. NPW had the highest levels in the lung, 
whereas neither GPR7 nor NPB showed any appreciable levels, followed by stomach, 
spinal cord, spleen, and hypothalamus. The high levels of gene expression of the 
peptides in tissues where GPR7 is not highly expressed suggests that these ligands could 
act as secreted endocrine hormones that are synthesized in these tissues and travel to the 
CNS or other areas that have high levels of GPR7. Furthermore, the disparate 
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Figure 29) Tissue distribution of GPR7, N P B and N P W in mice. Taqman® real time RT-PCR was used to 
analyze differential tissue expression in an adult male C57BL/6J wildtype mouse for G P R 7 (A), N P B (B) 
and N P W (C). All samples were normalized to cyclophilin expression levels and are expressed as a 
relative value compared to whole brain expression (i.e., a value of 1 is equivalent to the expression levels 
found in whole brain/cyclophilin). Hyp = hypothalamus; Int = small intestine; Sp cord = spinal cord; 
W A T = white adipose tissue. 
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T h e gene expression levels of the ligands, N P B and N P W , were investigated in 
the hypothalami of male GPR7-/- mice. Neither NPB nor NPW changed expression 
levels to compensate for the loss of GPR7 in either 24 or 52 week old male mice (Figure 
30). This could be due to lack of transcriptional regulation of the peptide ligands in the 
hypothalamus or as a loss of compensatory changes in aging GPR7-/- mice. The levels 
in peripheral tissue such as stomach were not measured. 
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Figure 30) Hypothalamic N P B and N P W levels in adult G P R 7 mice. Taqman® real-time RT-PCR 
analysis was conducted on hypothalami from 24 week old (A-B) and 52 week old (C-D) adult male mice 
for N P B (A, C) and N P W (B, D). * denotes a significant difference compared to GPR7+7+ littermates 
from the same age group. Note that there is no significant difference between GPR7+/+ and GPR7- -
mice for any of the gene expression levels at either age groups. 
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Effects of Feeding and Metabolic States on the Regulation of N P B , N P W , and G P R 7 
The data from the GPR7 knockout mice strongly suggested that NPB and NPW 
could serve as an anorectic signaling peptide ligand. Two separate age groups of male 
C57BL/6J wildtype mice were investigated for the effects of various feeding states on 
gene expression of GPR7 and its ligands in different tissues. The first younger set of 14 
week old wildtype mice was separated into three different cages with five animals each. 
One group was fasted for 48 hours, another had the water bottle removed (thirsting 
group) for 48 hours, and the last group was a control group that had free access to both 
food and water. Both the fasted and thirsted group lost significant body weight 
compared to the control group (Figure 31a). The hypothalamic levels of NPB, NPW 
and GPR7 in each group under the three conditions (fed, fasted 48 hours, and thirsted 48 
hours) were investigated. There was no significant difference in the hypothalamic levels 
of NPB or GPR7, but there was a modest trend towards decreased NPW levels after 
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Figure 31) Effects of 48 hours of fasting and thirsting (dehydration anorexia) on hypothalamic N P B , N P W , 
and G P R 7 gene expression levels. A ) Percent body weight change under 48 hour fast or 48 hour 
dehydration anorexia conditions for young adult (14 week old) C57BL/6J male mice. Both fasting and 
thirsting mice weighed significantly less than fed control groups after 24 hours (day 1) and 48 hours (day 2). 
B-D) Hypothalamic levels of N P B (B), N P W (C), or G P R 7 (D) under these conditions. N o significant 
differences were seen in any of the different groups. 
T h e older set of wildtype mice w a s separated into three different cages with five 
animals each. O n e group w a s fasted for 4 8 hours as before, the second group w a s fasted 
for 4 4 hours and food w a s reintroduced to the cages for 4 hours of refeeding, and the 
third group had free access to both food and water. T h e fasting group lost a significant 
amount of body weight compared to the fed control (Figure 32). The 4 hour refeeding 
group had noticeably distended stomachs and could represent a state of "gastric 
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distension" as well as a satiated state. Due to the high levels of gene expression of the 
peptide ligands in the stomach, it was hypothesized that NPB and/or NPW could 
potentially act as an anorectic gut peptide in a similar but opposite fashion as the recently 
identified gut peptide ghrelin (Kojima et al., 1999; Nakazato et al., 2001; Tschop et al., 
2000). Therefore, levels of gene expression for the ligands were examined in the 
stomach as well as the hypothalamus. 
As with the earlier experimental group, hypothalamic levels of NPB, NPW and 
GPR7 did not significantly change upon fasting or refeeding (Figure 33). However, 
stomach levels of NPW significantly decreased upon fasting (Figure 34b, d), while 
stomach levels of NPB paradoxically and in an opposite fashion increased with fasting 
and decreased significantly with refeeding (Figure 34a, c). NPW appears to follow a 
pattern typical of a catabolic signal, while NPB appears to be more similar to an anabolic 
signal. These opposing effects of fasting on stomach NPW and NPB could perhaps 
explain the biphasic feeding response seen after bolus ICV administration of the ligand 
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Figure 32) Change in body weight in adult male C57B1/6J mice after a 48 hour fast. Mice were separated 
into three different groups: fed control group (black squares), 48 hour fasted group (red crosses), and a 44 
hour fasted with 4 hour of refeeding group (blue triangle). After 44 hours of fasting, the fasted and 
refeeding groups had significantly lower changes in body weight compared to the fed control group 
(p<0.05, n=5 all groups) 
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Figure 33) Hypothalamic expression levels after a 48 hour fast. T a q m a n ® real-time RT-PCR analysis of 
hypothalamic levels of N P B (A), N P W (B), G P R 7 (C), and N P Y ( D ) . H y p = hypothalamic. * denotes a 
significant difference compared to fed states (n=5 in all groups). All samples were normalized to 
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Figure 34) Stomach NPB and NPW expression levels after a 48 hour fast. A-B) Northern blot analysis of 
stomach N P B (A) and N P W R N A (B). All samples were normalized to U V intensity of 28S r R N A band. 
C-D) Taqman® real time RT-PCR analysis of the same samples. All samples were normalized to 
cyclophilin expression as before. * denotes a significant difference compared to fed states (n=5 in all 
groups). 
Finally, possible regulation of stomach NPB and NPW by leptin was examined 
in female ob/ob mice that were chronically treated with a subcutaneous pump containing 
leptin (400ng/hour). Subcutaneous chronic leptin infusion at this high dose led to a 
dramatic decrease in body weight and food intake compared to PBS control ob/ob 
animals (Figure 35a, b). The effects were comparable to previously published results 
(Halaas et al., 1997; Soukas et al., 2000). 
Previously, it was shown that disrupting GPR7 on an ob/ob background resulted 
in an additive body weight gain (Figure 26a). Hypothalamic neuropeptide profile of the 
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GPR7-/- mice was also suggestive more of a lean state. Therefore, it appears that G P R 7 
signaling affects energy homeostasis independent of leptin signaling. This result was 
further confirmed when we analyzed the RNA or cDNA levels of stomach NPB or NPW 
in leptin treated ob/ob mice. While different metabolic states such as fasting can alter 
stomach levels of NPB and NPW, chronic leptin treatment for twelve days had no effect 
on NPB and NPW RNA levels compared to twelve day PBS treated or pair-fed animals 
(Figure 35c, d). 
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Figure 35 A-B) Chronic subcutaneous leptin administration's effect on stomach NPB and NPW expression 
levels. A) Percent body weight change of adult female ob/ob mice treated with leptin. PBS control, or 
pair-fed (n=4-6 in each group). B) Food intake of adult female ob/ob mice treated with leptin, PBS 
















$ 0,6 s °-4
| 0.2 
0 
d12PBS d12 LEP d12 PF d12PBS d12LEP d12 PF 
Figure 35 C-D) Chronic subcutaneous leptin administration's effect on stomach NPB and NPW expression 
levels. Taqman® real time RT-PCR analysis of stomach expression levels of NPB (C) and N P W (D) in 12 
day treated ob/ob mice (dl2 LEP) compared to PBS control (dl2 PBS) and pair-fed animals (dl2 PF). 
There were 4 to 6 animals in each group. No significant differences were seen in all groups for either 
stomach NPB or N P W levels. Similar results were obtained by Northern blot analysis (data not shown). 
Behavioral Analysis of GPR7-/- mice 
The initial study of the GPR7-/- mice focused on analyzing the effects on energy 
homeostasis due to G P R 7 being initially identified as a gene down-regulated after G T G 
treatment. However, the localization of the GPR7 and its ligands to various discrete 
locations in the brain suggests the possibility that G P R 7 signaling has other physiological 
roles. In particular, strong GPR7 mRNA levels have been found in the hypothalamus, 
hippocampus, amygdala, and ventral tegmental area (Lee et al., 1999; O'Dowd et al., 
1995). These areas are known to be involved in regulating a wide range of behavioral 
functions including anxiety, stress, fear, depression, and arousal (Nestler ct al., 2002; 
Nestler et al., 2001; Walker et al., 2003). Therefore, we investigated the role of GPR7 
for possible disturbances in a few key behavioral modalities including sleep regulation. 
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circadian rhythm, anxiety, and depression. 
Sleep Recordings - Investigating the potential role of G P R 7 in sleep homeostasis 
Sleep is critically protected under a tightly regulated homeostatic system. In 
mammals, the sleep-wake cycle is divided into three distinct states each with defined 
behavioral and neurophysiological characteristics (Jones, 1998). Sleep activity is 
monitored in mammals by using an electroencephalography (EEG), which measures 
electrical activity from the brain, and electromyography (EMG), which measures 
electrical activity from muscles. During wakefulness, the first stage in the sleep-wake 
cycle, the animal is fully conscious, which is associated with low-voltage, mixed 
frequency, fast activity on EEQ purposeful eye movements, and high muscular tone and 
activity on EMG. Non-REM sleep or slow-wave sleep is characterized as when an 
animal is behaviorally quiet and progressively becoming unresponsive to environmental 
stimuli. It is associated with high-voltage slow activity on EEG, absent eye movement, 
and reduced muscular tone and activity on EMG. REM sleep is characterized as when 
an animal is behaviorally quiet and further unresponsive to environmental stimuli. The 
EEG reading during REM sleep is similar to that during wakefulness with low voltage 
fast activity. Tonic muscle tone is completely absent; however, there can be frequent 
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twitches and small movements in the extremities. Sleep normally progresses from 
wakefulness to non-REM sleep to REM sleep. 
A recent study reported that a single bolus ICV injection of 400pmoles (lug) of 
NPW into the lateral ventricles of rat increased the amount of REM sleep to 14.34% 
compared to 6.7% when only vehicle was injected (Winsky-Sommerer et al., 2003). 
This suggested that GPR7 signaling could modulate REM sleep in mammals. In order 
to investigate the possible role of GPR7 in maintaining the sleep-wake cycle, custom 
EEG/EMG electrodes were implanted into adult male GPR7 mice for recording of normal 
baseline sleep-wake cycle. EEG/T3MG recordings were taken for three consecutive days. 
No mice showed any signs of spontaneous epileptic seizures in the EEG/EMG recordings. 
Typical hypnograms for the mice are shown (Figure 36). There were no significant 
differences between the GPR7+/+ and GPR7-/- groups in any of the sleep state 
parameters measured included time spent in REM sleep, and the measured results were 
similar to previously published data for wildtype mice (Figure 37, Table 4) (Chemelli et 
al., 1999; Hara et al., 2001; Willie et al., 2003). Furthermore, there was no 
fragmentation of the sleep or wake cycles as seen in narcoleptic orexin knockout mice 
nor evidence of spontaneous seizures (Chemelli et al., 1999). This data strongly 
suggests that GPR7 does not play a significant role in regulating basal sleep homeostasis. 
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A. A w a k e 
Figure 36) Example of E E G and E M G Recordings of different sleep-wake states in adult mice. A) Awake 
B) N o n - R E M sleep or slow wave sleep C) R E M sleep or paradoxical sleep. E E G recordings are depicted 
at the top of each chart with the corresponding simultaneously measured E M G recordings on the bottom 
half. Each 20 second epoch (one full screen) was manually scored offline based on precious criteria. 
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Figure 37) T i m e spent in each sleep state for adult male G P R 7 mice by E E G recordings. Data w a s 
recorded for three consecutive 24 hour periods, scored offline with custom software, and averaged for a 24 
hour day. (black squares = GPR7+/+ ( W T ) males; red crosses = GPR7-/- (KO) males; n=4/genotype). N o 
significant difference between GPR7+/+ and GPR7-/- mice at any time point for any of the sleep states. 
Table 4: Summary of baseline sleep recordings for male GPR7+/+ ( W T ) and GPR7-/- (KO) mice 
24 hours 
Total time (min) 
Episode duration (sec) 
REM latency (min) 
Inter-REM interval (min) 
Light period 
Total time (min) 
Episode duration (sec) 
REM latency (min) 
Inter-REM interval (min) 
Dark period 
Total time (min) 
Episode duration (sec) 
REM latency (min) 


























































Four animals of each genotype were used (one animal in each genotype was discarded due to poor 
E E G / E M G signal output). Data was collected for three consecutive 24 hour days, scored offline with 
custom software, and averaged for 24 hours. N o significant difference in any of the categories between 
GPR7+/+ and GPR7-/- mice. 
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Circadian Rhythm in GPR7-/- Mice 
Mounting experimental evidence from rodents has shown the suprachiasmatic 
nucleus to be the site of the master circadian pacemaker in mammals (van Esseveldt et al., 
2000). With strong localization of GPR7 signal in the suprachiasmatic nucleus, it was 
postulated that mice lacking GPR7 signaling might have disruptions in their circadian 
rhythm. Several behaviors are governed by circadian rhythm including hormonal 
control, feeding, body temperature, cardiac function, and sleeping (Rutter et al., 2002). 
Disruption of circadian rhythm could affect any of these behaviors. 
Running wheel cages are frequently used to reproducibly monitor circadian 
rhythms in mice (King and Takahashi, 2000). To analyze the circadian behavior of 
GPR7-/- mice, commercial automated home cage running wheels were used. Adult 
female mice were removed from their group-housed home cages and individually placed 
into the running wheel equipped cages. After an acclimation period of a week, running 
wheel behavior was recorded over a week under a 12:12 LD (light, dark) cycle. There 
was no significant difference in the periods between the genotypes in the circadian 
rhythm of a normal 12:12 LD cycle (Figure 38, Table 5). Light entrainment was 
removed, and free running wheel behavior of the mice placed on a strict 12:12 DD (dark, 
dark) cycle was monitored. Again, no significant differences were seen between the 
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genotypes (Figure 3 8 , Table 5). Furthermore, all m i c e w e r e able to maintain a strict 
circadian rhythm without light entrainment for the duration of the study. While GPR7 
does not appear to grossly regulate circadian rhythms, longer study durations or different 
entrainment techniques, such as with feeding, may yield subtle effects of GPR7 signaling. 
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Figure 38) Representative running wheel behavior actagram double plots for adult female G P R 7 mice. 
Both female G P R 7 + / + (A) and GPR7-/- (B) mice maintained a circadian rhythm after light entrainment was 
removed. L:D = 12 hour light:dark cycle; D:D = 12 hour dark:dark cycle. 
tau (period) 







Table 5) tau (Period) calculations for adult female G P R 7 mice. Mice were placed in individual cages 
equipped with a running wheel. The activity was recorded automatically by a computer for a total time 
period of 7 full days. Period calculations were performed using software based on chi-square 
periodogram algorithm. No significant differences were seen between the genotypes or the different light 
cycles (LD = 12 hour light:dark cycle; DD = 12 hour dark:dark cycle). 
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Anxiety of GPR7-/- Mice - Open Field and Elevated Plus Maze 
Stress and anxiety are strong mediators of energy homeostasis. Abnormally 
high levels of the stress hormone Cortisol in humans lead to a condition called Cushing's 
syndrome, which is associated with altered fat distribution and increased visceral obesity 
(Peeke and Chrousos, 1995). Glucocorticoids such as Cortisol are essential in 
maintaining obesity. Adrenalectomy reverses the obesity seen in ob/ob mice, while 
treatment with glucocorticoids can restore the obese state (Naeser, 1973; Shimomura et 
al., 1987; Solomon and Mayer, 1973). Also, central factors that regulate energy 
homeostasis often overlap with those involved in regulating anxiety-like behaviors. 
including corticotropin releasing factor (CRF) and related peptide pathways and the 
serotonin signaling pathways (Heisler et al., 2002; Steckler and Holsboer, 1999). Both 
the CRF and serotonin pathways have some of their respective receptors in the same 
neuronal regions that express GPR7. Therefore, GPR7-/- mice were investigated for 
anxiety-like behaviors that potentially could explain the abnormal regulation of energy 
homeostasis. 
Anxiety-like behavior was measured by two commonly used methods: the open 
field test and the elevated plus maze. Both the open field test and the elevated plus 
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maze are based on the principle that there is a conflict between the tendency of a mouse 
or rat to explore a novel area and its innate aversive behavior towards brightly lit, open 
areas (Crawley, 2000). In the open field test, a mouse is placed in a large lit open area 
with no dark corners. The initial reaction is for the mouse to avoid the large open center 
area. However, as anxiety to the new location diminishes, the mouse will start to 
explore more of the open field including the open center area. The time spent in the 
center of the open field is used as a measure of anxiety-like behavior. Administering 
anxiolytic drugs to a mouse prior to exposure to the open field will increase the time the 
mouse spends in the center. The elevated plus maze is similar in concept. There are 
two open arms and two closed arms on an elevated platform. The mouse tends to stay in 
the closed, darker arms due to their initial anxiety to the novel environment. Again, as 
the anxiety diminishes, the mouse has a greater tendency to explore the environment and 
spend more time in the open arm. Administering anxiolytic drugs prior to exposure to 
the elevated plus maze can increase the amount of open arm entries and the time the 
mouse spends in the open arms. 
The initial screening was conducted on a small sample of adult mice using an 
automated open field test apparatus (UT Southwestern). During this screen, adult male 
GPR7-/- mice showed a trend towards decrease in overall locomotive activity and a 
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significant increase in time spent in the center (Figure 39). W h e n the time spent in 
center for the male GPR7A mice was corrected for locomotive activity, they still showed 
a significant increase compared to GPR7+/+ mice (Figure 39). Female GPR7-/- mice 
showed no significant differences from GPR7+/+ littermate controls in total distance 
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Figure 39) O p e n field analysis of adult male G P R 7 mice using an automated system. A - B ) Total distance 
traveled (A) and time spent in the center of the open field (B) analyzed per minute of the fifteen minute test 
period. C-E) Total distance traveled (C) and time spent in the center (D-E) for the s u m of the fifteen minute 
test period. All tests were scored automatically by the provided software. *denotes a significant 
difference between G P R 7 + / + and GPR7-/- mice. All testing w a s conducted at University of Texas 
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Figure 40) Open field analysis of adult female G P R 7 mice using an automated system. A-B) Total 
distance traveled (A) and time spent in the center of the open field (B) analyzed per minute of the fifteen 
minute test period. C-D) Total distance traveled (C) and time spent in the center (D) for the sum of the 
fifteen minute test period. All tests were scored automatically by the provided software. All testing was 
conducted at University of Texas Southwestern Medical Center (Dallas, Texas). N o significant 
differences were seen between female G P R 7 + / + and GPR7-/- mice. 
However, w h e n a different set of adult male or female G P R 7 mice w a s tested in 
another open field test apparatus in a different location (Rockefeller University), there 
was no significant difference in latency to center or the time spent in the center between 
G P R 7 + / + and GPR7-/- for cither sex (Figure 41). The discrepancy between the two 
separate test runs could be attributed to the different testing apparatuses, location and 
environment. Most notably the open field dimensions were of different sizes. Scoring 
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between the two apparatuses w a s also different as the first w a s automatically scored by a 
computer using infrared laser beams, while the second relied on human manual scoring of 
videotapes. Furthermore, behavioral measurements in mice including the open field and 
elevated plus m a z e are very sensitive to changes in the environment even if the testing 
conditions are nearly identical (Crabbe et al., 1999). 
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Figure 41) Open field analysis of G P R 7 mice using a manual test apparatus. A fifteen minute open field 
analysis was conducted using a different testing apparatus in a new location (Rockefeller University, New 
York). All mice were manually scored for latency to center of open field (A, C) and time spent in the 
center field after 15 minutes (B, D). No significant differences were seen in any of the groups. 
A n elevated plus m a z e w a s used to further investigate potential anxiety-like 
behaviors in G P R 7 mice. Similar to the o p e n field test, there w a s n o significant 
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difference between the genotypes in time spent in the open or closed arms or the ratio 
between the number of entries of the open to the closed arms (Figure 42). The larger 
sample size and the use of two different tests suggest that the decrease in anxiety-like 
behavior originally seen in the first test run of male GPR7-/- mice was most likely an 
artifact. Therefore, GPR7 signaling does not appear to mediate anxiety-like behaviors. 
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Figure 42) Elevated plus maze test on adult GPR7 mice. The same set of adult mice as used for the 
previous open field test was used. Only mice that stayed on the elevated plus maze throughout the testing 
period without falling were counted. Mice were scored manually for five minutes and analyzed for total 
number of arm entries (A), ratio of open to total arm entries (B), and the total time spent in the closed ami 
(C) and in the open arm (D). No significant differences were seen. 
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Depression in GPR7-/- Mice - Forced Swim Test 
Adult male GPR7A+ and GPR7-/- mice were evaluated for depression-like 
behaviors by a modified Porsolt forced swim test (Lucki, 1997; Lucki et al., 2001; Porsolt 
et al., 1977a). In this test, an animal is placed in an enclosed cylinder filled with water, 
where it can not reach the bottom of the cylinder floor or escape out of the cylinder in any 
direction. The time spent immobile is a reproducible measure of depression-like 
behavior that has been shown to be corrected by anti-depressant drugs (Cryan et al., 
2002; Porsolt et al, 1977b). An initial group of naive adult male GPR7-/- mice were 
tested and showed no significant differences in the time spent immobile compared to 
GPR7A+ mice (Figure 43). These mice were all originally group housed with their 
littermates. In order to stimulate depression and anxiety-like behavior, the mice were 
isolated from each other by single-caging the test animals. Following four weeks of 
social isolation, the mice were tested again in the same forced swim test. As before, 
there were no significant differences in the time spent immobile between GPR7A+ and 
GPR7-/- male mice (Figure 43). These data suggest that GPR7 signaling does not 
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Figure 43) Forced swim test for depression analysis in adult male GPR7-/- mice. Group housed male 
mice, naive to the swim test, were initially tested for the time spent immobile in a swim tank (GPR7+/+ 
n=7; GPR7-/- n=6). After the initial test, the same mice were individually caged and socially isolated for 
four weeks and retested under the same conditions as before. 
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Chapter 4: Discussion 
The results reported here detail the role of G P R 7 signaling in regulating energy 
homeostasis in mammals in a potentially sexually dimorphic manner. Numerous lines 
of evidence from the phenotype of GPR7-/- mice to the differential gene regulation of the 
ligands to the in vivo pharmacological effects of the ligands in rodents have shown that 
GPR7 and its ligands are involved in regulating feeding and body weight. Other 
possible physiological roles for GPR7 signaling in mammals were also investigated 
including the regulation of the sleep-wake cycle, circadian rhythm, anxiety, and 
depression; however, none of the behavioral tests on the GPR7-/- mice showed a 
significant role for GPR7 in controlling these behaviors. 
We first identified GPR7 as a candidate obesity gene due to a decrease in 
hypothalamic gene expression levels following GTG treatment in mice. This suggested 
that GPR7 was in the same neuronal population as those involved in the VMH mediated 
regulation of body weight and food intake. GPR7 mRNA expression pattern in the 
rodent brain is also consistent with a role in energy homeostasis. GPR7 is expressed in 
the arcuate and VMH of the hypothalamus, as well as in other regions known to regulate 
feeding, neuroendocrine pathways and the autonomic nervous system (Lee et al., 1999; 
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O'Dowd et al., 1995). Furthermore, G P R 7 was identified as an orphan G P C R with 
potentially a novel peptide ligand. Orphan GPCRs are heavily investigated by both 
academic institutions and pharmaceutical companies. GPCRs and their target ligands 
currently constitute the largest drug target group with greater than 30% of the 500 
clinically marketed drugs being modulators of GPCRs (Drews, 2000; Wise et al., 2004). 
It is also worth noting that many of the known factors involved in regulating energy 
homeostasis act through GPCRs. This includes the melanocortins, NPY and its related 
family members, MCH, CRF, orexins, ghrelin, serotonin, and many others. Therefore, 
the potential for finding new avenues in energy homeostasis research by unmasking the 
function of a novel orphan GPCR family was significant. 
The physiological role of the then orphan receptor, GPR7, was investigated by 
generating mice with targeted disruption of the GPR7 gene. Male GPR7-/- mice display 
a moderate adult-onset obese syndrome that is greatly exacerbated when fed a high fat 
diet. The moderate adult-onset obesity seen in GPR7-/- male mice is similar in 
magnitude to that seen in knockout mice for other anorectic hypothalamic genes. These 
include hormones and receptors involved in the melanocortin (MC3R) and 
cocaine-amphetamine-related peptide pathway (Asnicar et al., 2001; Yaswen et al., 1999); 
bombesin receptor subtype-3, an orphan GPCR from the bombesin peptide receptor 
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family (Ohki-Hamazaki et al., 1997); and other anorexigenic signals such as serotonin 
5HT2C receptor (Nonogaki et al., 1998) and IL-6 (Wallenius et al., 2002). Many of these 
signaling molecules are components of a complex network that also includes leptin. 
Leptin maintains energy homeostasis by at least in part changing various RNA levels of 
hypothalamic neuropeptides (Friedman and Halaas, 1998). In male GPR7A mice, the 
hypothalamic RNA levels of NPY and POMC RNA were more characteristic of a lean 
rather than a leptin deficient state. In addition, both Ay/a GPR7-/- and ob/ob GPR7-/-
male mice were heavier than their respective Ay/a and ob/ob GPR7A+ littermates. Thus, 
GPR7 signaling is not epistatic to leptin or melanocortins and rather appears to affect 
energy homeostasis by a novel mechanism independent or parallel to leptin and 
melanocortin signaling. 
The peptide ligands for GPR7, NPB and NPW, have been recently identified by 
several groups using reverse pharmacology and computational genomics (Brezillon et al., 
2003; Fujii et al., 2002; Shimomura et al., 2002; Tanaka et al., 2003). NPB and NPW 
are derived from two different novel genes and represent a new uncharacterized 
peptide-receptor family. Both peptide ligands have subnanomolar to nanomolar affinity 
for GPR7 and its homolog GPR8, which is absent in rodents. NPB and NPW are 
expressed both centrally and in the periphery (Fujii et al., 2002; Tanaka et al., 2003). 
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N P B and N P W are localized in different and discrete neuronal populations. N P B had a 
wider distribution in the rodent brain than NPW (Tanaka et al., 2003). Peripheral 
expression for both ligands was exceptionally strong in the stomach with NPW also 
having very high levels in the lungs (Tanaka et al., 2003). These results were 
confirmed with Taqman® real-time RT-PCR and Northern blot analysis from our lab. 
The distinct expression patterns of NPB and NPW in the brain and periphery suggest 
separate physiological roles for the ligands even though both act most likely on one 
common receptor GPR7 in rodents. 
The pharmacological effects of NPW or NPB on feeding behaviors have been 
recently studied. An intracerebroventricular (ICV) bolus injection of NPB at the onset 
of the dark phase elicits a biphasic feeding response with an initial small and transient 
increase in food intake followed by a much more significant, sustained suppression of 
food intake during the dark cycle (Tanaka et al., 2003). Rats injected with NPB also 
have increased locomotor activity (Tanaka et al., 2003). The hypophagia and 
hyperlocomotion in rodents after an ICV injection of NPB correlate well with the 
phenotype of GPR7-/- male mice. Chronic ICV infusion of NPW in rats lead to 
sustained weight loss, decreased food intake, and increased heat production and body 
temperature without any signs of transient hyperphagia (Mondal et al., 2003). The data 
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from the chronic ICV infusion of N P W and the obese phenotype of the GPR7-/- mice 
further suggest that the transient increase in food intake is not likely to be biologically 
significant, at least over the long term. Toxic, aversive or nonspecific effects of NPW 
on feeding were also ruled out as ICV administration of NPW did not reduce saccharin 
consumption in a conditioned taste aversion test (Mondal et al., 2003). Therefore, in 
aggregate with the genetic evidence from GPR7-/- mice, the current pharmacological 
evidence for the ligands of GPR7 strongly suggests that GPR7 signaling serves as an 
endogenous catabolic signal. 
Furthermore, it is not known whether NPB and NPW exert its actions directly as a 
neuropeptide locally in the brain or if the peptides are also released as an endocrine 
hormone into the blood stream from peripheral tissues such as the stomach. Several 
brain-gut peptides play a prominent role in regulating feeding and energy homeostasis 
including cholecystokinin (CCK), bombesin, glucagons-like peptide 1, pancreatic 
polypeptide, peptide YY 3-36 (PYY3-36), and ghrelin. Many of these peptides have 
been shown to be synthesized in the gut and then potentially released as peptide 
hormones to act on central sites including the hypothalamus. Both pancreatic 
polypeptide and PYY3-36 are part of the NPY peptide family and have been shown to 
inhibit feeding when administered peripherally (Asakawa et al., 2003; Batterham et al., 
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2002). P Y Y 3 - 3 6 has been suggested to bind and activate preferentially N P Y Y 2 
receptors in the hypothalamus leading to decreased levels and activity of the orexigenic 
signal N P Y (Batterham et al., 2002). With the differential regulation of stomach N P W 
levels following a 48 hour fast, there is some evidence to support a peripheral role for 
N P B and N P W in regulating feeding and energy homeostasis. The ligands for G P R 7 
could potentially act in a similar fashion as pancreatic polypeptide or P Y Y 3 - 3 6 as a gut 
endocrine peptide that exerts an anorectic effect through receptors, found appreciably 
only in nervous tissues, located in the hypothalamus (Figure 44). 
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Figure 44) Regulation of energy homeostasis by Neuropeptide B and Neuropeptide W signaling pathways 
from peripheral tissues to the central nervous system. In this model. NPB and NPW could be synthesized 
and secreted from peripheral tissues that have very high R N A levels of the ligands such as the stomach and 
lung. Alternatively, the ligands could be working locally in the hypothalamus or could be secreted from 
extra-hypothalamic neurons. The exact nature of the signaling pathway is currently unknown. 
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Many catabolic signals are physiologically regulated under different metabolic 
conditions especially under starvation. Starvation leads to a wide change in metabolic 
and neuroendocrine function (Schwartz and Seeley, 1997). Hypothalamic 
orexigenic/anabolic signals are strongly induced, while hypothalamic anorectic/catabolic 
signals are decreased (Ahima et al., 1999; Schwartz et al., 1995). This constellation of 
changes in the hypothalamic regulation of energy homeostasis serves to coordinate an 
appropriate response to depletion of fuel stores until they are replenished. Fasting mice 
for 48 hours increased expression levels of hypothalamic NPY, a potent 
orexigenic/anabolic signal, as expected, but it had no effect on hypothalamic levels of 
NPB, NPW, or GPR7. While hypothalamic levels did not change, stomach levels of 
NPW decreased with fasting as would be expected for a catabolic signal. Many of these 
neuroendocrine changes seen during starvation in rodents are mediated by a fall in leptin 
levels (Ahima et al., 1996). While different energy states such as a 48 hour fast can 
significantly decrease stomach NPW RNA levels, chronic leptin treatment had no 
significant effect on the transcriptional regulation of the ligands in the stomach. 
Besides plasma leptin levels, several other factors that may regulate energy 
homeostasis such as blood glucose, ketone, free fatty acid, growth hormone levels and 
many others are also affected by starvation (Cahill et al., 1966; Sims and Horton, 1968). 
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Changes in glucose levels are known to affect firing of glucose-sensitive and 
glucose-responsive neurons in the LH and VMH respectively (Oomura, 1983). It is 
appealing to think that changes in blood glucose levels could be the physiological input 
signal for GPR7 and its ligands. However, while the refeeding response after a 24 hour 
fast was abnormally high in GPR7-/- mice, GPR7-/- mice had a normal feeding response 
to glucoprivation after peripheral or central administration of moderate doses of the 
glucose analog 2-deoxy-D-glucose. These data suggest that central glucose signaling in 
GPR7-/- mice are normal, and therefore glucose is not the main factor in regulating 
GPR7 signaling. Some other factor that changes under starvation such as glucocorticoid, 
free fatty acid, amino acid, or ketone levels may serve as an important input signal to 
GPR7 signaling. Alternatively, stomach NPW levels may be responding to the physical 
distension/emptying of the stomach similar to the classical model of CCK and other gut 
peptides (Read et al., 1994). 
While the physiological input(s) modulating GPR7 signaling is not known, the 
effects of defective GPR7 signaling are sexually dimorphic in mice. Body weight in 
mammals is known to be sexually dimorphic. In humans, females tend to be more 
obese than males, while in mice, males are more obese than females (Cortright and Koves, 
2000). Other animal models of hypothalamic obesity including the NPY Y1R-/- mice 
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and the N P Y Y5R-/- mice have also shown sexual dimorphism in body weight. In 
contrast to GPR7-/- male mice, NPY Y1R-/- females weighed more than male NPY 
Y1R+/+ mice, while similar to GPR7-/- male mice, NPY Y5R-/- weighed more than 
female NPY Y5R-/- (Marsh et al., 1998; Pedrazzini et al, 1998). In mice, castrating 
males result in decreased adiposity, whereas ovariectomizing females result in increased 
adiposity indicating a strong role for sex hormones in regulating body weight (Wright and 
Turner, 1973). While estrogens and androgens clearly modulate long term energy 
homeostasis in mammals, the underlying mechanisms are unclear (Heine et al., 2000; 
Jones et al., 2000). Additional investigation of the sexually dimorphic effects on body 
weight of GPR7-/- mice could lead to further elucidation of the mechanism(s) by which 
sex hormones regulate energy homeostasis. 
Although it is reasonable to speculate that NPB and NPW modulate food intake 
and energy homeostasis by binding to GPR7 in hypothalamic neurons, it is possible that 
the effects are not directly mediated by hypothalamic feeding-related neurons. As 
previously mentioned, GPR7 is expressed in several discrete areas in the brain. There is 
strong evidence that many of these areas are involved in regulating different behavioral 
patterns from anxiety to depression. Feeding disorders and mood disorders have at least 
a strong association as evident in several human clinical trials and epidemiological 
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studies (McElroy et al., 2004). Disturbances of diverse physiological systems from 
stress, fear, and anxiety responses to disruption of affective and emotive responses to 
feeding could possibly account for all of the "metabolic" phenotypes observed in the 
GPR7-/- mice. However, in our initial screen for behavioral abnormalities in the 
GPR7-/- mice including the open field and elevated plus maze as well as the Porsolt 
forced swim test, we found no significant differences compared to GPR7+/+ littermates 
in anxiety or depression-like behaviors. This does not rule out the possibility for some 
more complex or other behavioral role for GPR7 signaling such as conditioned fear 
responses or learning and memory, but it suggests that gross abnormalities in a few key 
behavior paradigms studied do not mediate the obesity syndrome seen in GPR7-/- mice. 
NPB and NPW have other pharmacological effects not directly related to 
maintaining energy homeostasis including enhancing analgesia, stimulating the release of 
prolactin, and increasing REM sleep (Shimomura et al., 2002; Tanaka et al., 2003; 
Winsky-Sommerer et al., 2003). While the role of GPR7 in analgesia and stimulating 
prolactin secretion still remains to be investigated, the sleep-wake cycles in GPR7-/- mice 
have been monitored. The baseline sleep-wake parameters are essentially identical 
between GPR7+/+ and GPR7-/- mice. Therefore, the increased REM sleep seen after 
central administration of NPW is either non-specific or largely insignificant for normal 
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sleep homeostasis. The availability of GPR7-/- mice now provides an opportunity to 
further distinguish non-specific drug effects of NPB and NPW from physiological effects 
by comparing the ligands' effects on wildtype versus GPR7-/- mice. Thus, future 
studies of the effects of these peptides on body weight and other systems in normal and 
GPR7-/- mice should establish the full range of functions of the peptides in vivo. Due to 
widespread NPB and NPW mRNA expression and sequence similarity of GPR7 to opioid 
and somatostatin receptors, which are known to have numerous disparate physiological 
roles, a pleiotropic role for GPR7 signaling would not be surprising. 
Further studies of GPR7 and its ligands will lead to a better understanding of its 
role in regulating energy homeostasis and possibly other behaviors. While some of the 
possible physiological inputs regulating GPR7's actions have been investigated, the exact 
nature of these inputs is still currently unknown. It appears that leptin and possibly 
glucose are not strong modulators. In order to further elucidate the nature of these 
inputs, the exact characteristics of the GPR7, NPB, and NPW-expressing neuronal 
population needs to be known. What are the other genes expressed in these neurons? 
Are they glucose-responsive neurons? Do these neurons respond to other metabolites 
such as free fatty acids? What are the inputs and outputs of the GPR7 expressing 
neuronal population? Some of these answers can be obtained by carrying out careful 
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immunohistochemical analysis of these neurons and subsequent electrophysiology. 
Unfortunately, the antibody against GPR7 that was generated in this lab proved to be too 
non-specific to be useful in answering these questions. The tau-GFP expression from 
the knock-in cassette was also too weak to be visualized by standard 
immunohistochemistry techniques. Labeling these neurons by generating BAC 
GPR7-GFP, NPB-GFP, and NPW-GFP transgenic mice might be useful in answering 
some of these questions (Liu et al., 2003; Yang et al., 1997). 
Also, the sexual dimorphic nature of the obesity seen in GPR7-/- mice can be 
followed by studying gonadectomized mice. It is reasonable to suspect that if sex 
hormones play a large role in the obesity syndrome of GPR7-/- mice, ovarectomizing 
GPR7-/- females (or mascularizing females) should cause them to become obese or 
weigh more than ovarectomized GPR7+/+ females. Conversely, castrating male 
GPR7-/- mice and administering estrogen should keep the mice lean. If a role for sex 
hormones in GPR7 signaling can be established, it would be fruitful to know whether the 
neurons expressing GPR7 and the ligands also colocalize with sex hormone receptors 
such as estrogen receptors. 
The possible separate and distinct physiological role of NPB and NPW could be 
demonstrated with the generation of specific individual general ligand knockout mice. 
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A double knockout of the ligands should be a phenocopy of the GPR7-/- mice unless 
another currently unknown receptor or ligand exists in the same pathway. While there is 
no evidence to support another receptor similar to GPR7 in rodents that NPB or NPW 
could activate, receptor autoradiography or radioligand binding studies on GPR7-/- mice 
could potentially prove or refute this possibility. The specific role of the ligands in the 
periphery could be probed with the generation of tissue specific knockout mice such as 
stomach specific knockouts of NPB and/or NPW. Additionally, the physiological role 
of the ligands in other peripheral tissues such as in lungs and immune cells is not known, 
but it is plausible that it is independent of its role in energy homeostasis. 
Finally, the physiological nature and role for the post-translation bromination of 
the tryptophan in NPB is unknown. Brominated and non-brominated NPB have 
indistinguishable binding and pharmacological activity both in vitro and in vivo (Tanaka 
et al., 2003). It is reasonable to speculate that bromination is important for stability of 
the neuropeptide. N-terminal tryptophans tend to be more sensitive to aminopeptidase 
degradation by the "N-end rule" (Varshavsky, 1996), and bromination may block this 
degradation. It is known that loss of the N-terminal tryptophan in either NPB or NPW 
leads to a dramatic loss in binding and activity of the peptides (Tanaka et al., 2003). If 
this is true, then it is curious that brominated forms of NPW, which would presumably 
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face a similar stability problem without bromination, have not been found. Furthermore, 
the mechanism for tryptophan bromination remains a mystery. It would be exciting to 
speculate about the possible existence of a novel mammalian tryptophan brominating 
factor that has yet to be discovered. While nonspecific bromination of tyrosine residues 
by eosinophil peroxidase has been reported in patients with allergen-induced asthma, the 
identity and location of this putative brominating factor for NPB remains to be seen (Wu 
et al., 2000). 
Since the initial cloning of GPR7 as an orphan GPCR in 1995 to the generation of 
the GPR7-/- mice and the identification of NPB and NPW as the endogenous ligands of 
GPR7, many of the physiological functions of GPR7 signaling have now been elucidated 
(Table 6). In particular, NPB and NPW signaling via the GPR7 receptor plays a 
biologically important role as a catabolic signal in regulating food intake, energy 
expenditure and body weight. These data suggest the possibility that GPR7 agonists and 
other components of the GPR7 signaling pathway might have therapeutic benefits for 
treating obesity and related metabolic conditions. 
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Genetics refers to the phenotypes observed in GPR7-/- mice. Pharmacology data is from various bolus or 
continuous ICV administration of either N P B or N P W in rodents. References: 'Mondal et al., 2003; 
2Tanaka et al., 2003; 3Winsky-Sommerer et al, 2003; "Shimomura et al., 2002; 5Baker et al, 2003 
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